{
"description": null,
"_filename": "ATC_Antiinfectives.json",
"package_name": "noma.fhir.mpd",
"date": null,
"meta": {
"versionId": "1",
"lastUpdated": "2025-08-11T08:49:46.084+00:00"
},
"publisher": null,
"content": "complete",
"property": [ {
"code": "parentATC",
"type": "Coding",
"description": "Parent ATC"
}, {
"code": "fromDate",
"type": "Coding",
"description": "From Date"
}, {
"code": "toDate",
"type": "Coding",
"description": "To Date"
}, {
"code": "previousVersion",
"type": "Coding",
"description": "Previous Version"
}, {
"code": "ATCCode",
"type": "Coding",
"description": "ATC Code"
}, {
"code": "internalCode",
"type": "Coding",
"description": "Internal code"
}, {
"code": "termIdRms",
"type": "Coding",
"description": "RMS ID"
}, {
"code": "internalTermStatus",
"type": "Coding",
"description": "Status (internal)"
}, {
"code": "sourceTermStatus",
"type": "Coding",
"description": "Status (RMS)"
} ],
"name": "Anatomical Therapeutic Chemical classification system - Human - Antiinfectives for systemic use Examples",
"type": null,
"experimental": null,
"resourceType": "CodeSystem",
"title": null,
"package_version": "2.0.0",
"status": "active",
"id": "9dfdcdde-8de9-43d1-8269-0acfa0176c34",
"kind": null,
"url": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"identifier": [ {
"value": "e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"system": "http://legemiddelverket.no/fhir/SAFEST/SafestCodeSystemID"
}, {
"value": "100000095974",
"system": "http://legemiddelverket.no/fhir/SAFEST/ListID"
} ],
"concept": [ {
"code": "J07BN01",
"display": "Covid-19, RNA-based vaccine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BN",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J07BX03",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BN01",
"display": "J07BN01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-15T00:00:00Z",
"display": "2021-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BN01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Covid-19, RNA-based vaccine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Covid-19, RNA-basert vaksine",
"language": "no"
} ]
}, {
"code": "J01DD02",
"display": "Ceftazidime",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD02",
"display": "J01DD02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftazidime",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftazidim",
"language": "no"
} ]
}, {
"code": "J01CR01",
"display": "Ampicillin and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of penicillins, incl. beta-lactamase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CR01",
"display": "J01CR01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-02T00:00:00Z",
"display": "2018-01-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CR01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ampicillin and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ampicillin og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J01FA11",
"display": "Miocamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA11",
"display": "J01FA11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-10T00:00:00Z",
"display": "2014-11-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Miocamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Miokamycin",
"language": "no"
} ]
}, {
"code": "J07BD",
"display": "Measles vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BD",
"display": "J07BD"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BD"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Measles vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meslingvaksiner",
"language": "no"
} ]
}, {
"code": "J01FF",
"display": "Lincosamides",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01F",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides, lincosamides and streptogramins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FF",
"display": "J01FF"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-28T00:00:00Z",
"display": "2014-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FF"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lincosamides",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Linkosamider",
"language": "no"
} ]
}, {
"code": "J01MA11",
"display": "Grepafloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA11",
"display": "J01MA11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Grepafloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Grepafloksacin",
"language": "no"
} ]
}, {
"code": "J01AA06",
"display": "Oxytetracycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA06",
"display": "J01AA06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Oxytetracycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Oksytetrasyklin",
"language": "no"
} ]
}, {
"code": "J05AP14",
"display": "Narlaprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP14",
"display": "J05AP14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2025-01-01T00:00:00Z",
"display": "2025-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Narlaprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Narlaprevir",
"language": "no"
} ]
}, {
"code": "J05AB03",
"display": "Vidarabine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB03",
"display": "J05AB03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Vidarabine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Vidarabin",
"language": "no"
} ]
}, {
"code": "J05AB12",
"display": "Cidofovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB12",
"display": "J05AB12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cidofovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cidofovir",
"language": "no"
} ]
}, {
"code": "J01AA02",
"display": "Doxycycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA02",
"display": "J01AA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-07T00:00:00Z",
"display": "2013-10-07T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Doxycycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Doksysyklin",
"language": "no"
} ]
}, {
"code": "J07BD01",
"display": "Measles, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Measles vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BD01",
"display": "J07BD01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BD01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Measles, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meslinger, levende, svekket",
"language": "no"
} ]
}, {
"code": "J06AA01",
"display": "Diphtheria antitoxin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immune sera"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06AA01",
"display": "J06AA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06AA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria antitoxin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteriantitoksin",
"language": "no"
} ]
}, {
"code": "J01DB04",
"display": "Cefazolin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB04",
"display": "J01DB04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefazolin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefazolin",
"language": "no"
} ]
}, {
"code": "J01DC52",
"display": "Cefuroxime and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC52",
"display": "J01DC52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefuroxime and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefuroksim og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J04AB",
"display": "Antibiotics",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AB",
"display": "J04AB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antibiotics",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antibiotika",
"language": "no"
} ]
}, {
"code": "J01DB07",
"display": "Cefatrizine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB07",
"display": "J01DB07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefatrizine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefatrizin",
"language": "no"
} ]
}, {
"code": "J05AD",
"display": "Phosphonic acid derivatives",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AD",
"display": "J05AD"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AD"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Phosphonic acid derivatives",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fosfonsyrederivater",
"language": "no"
} ]
}, {
"code": "J01DC03",
"display": "Cefamandole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC03",
"display": "J01DC03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefamandole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefamandol",
"language": "no"
} ]
}, {
"code": "J07BD54",
"display": "Measles, combinations with mumps, rubella and varicella, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Measles vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BD54",
"display": "J07BD54"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BD54"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Measles, combinations with mumps, rubella and varicella, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meslinger, kombinasjoner med kusma, rubella og varicella, levende svekket",
"language": "no"
} ]
}, {
"code": "J05AX31",
"display": "Lenacapavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX31",
"display": "J05AX31"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX31"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lenacapavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lenakapavir",
"language": "no"
} ]
}, {
"code": "J01GB09",
"display": "Dibekacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB09",
"display": "J01GB09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dibekacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dibekacin",
"language": "no"
} ]
}, {
"code": "J05AP01",
"display": "Ribavirin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AB04",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Ribavirin"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP01",
"display": "J05AP01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ribavirin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ribavirin",
"language": "no"
} ]
}, {
"code": "J01ED07",
"display": "Sulfamerazine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED07",
"display": "J01ED07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfamerazine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfamerazin",
"language": "no"
} ]
}, {
"code": "J01FA09",
"display": "Clarithromycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA09",
"display": "J01FA09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-13T00:00:00Z",
"display": "2014-10-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Clarithromycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Klaritromycin",
"language": "no"
} ]
}, {
"code": "J02AC",
"display": "Triazole and tetrazole derivatives",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AC",
"display": "J02AC"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AC"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Triazole and tetrazole derivatives",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Triazol- og tetrazolderivater",
"language": "no"
} ]
}, {
"code": "J07AR",
"display": "Typhus (exanthematicus) vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AR",
"display": "J07AR"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AR"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Typhus (exanthematicus) vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Typhus (exanthermaticus) vaksiner",
"language": "no"
} ]
}, {
"code": "J06AA",
"display": "Immune sera",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immune sera"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06AA",
"display": "J06AA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06AA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Immune sera",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunsera",
"language": "no"
} ]
}, {
"code": "J01CE09",
"display": "Procaine benzylpenicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE09",
"display": "J01CE09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Procaine benzylpenicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Prokainbenzylpenicillin",
"language": "no"
} ]
}, {
"code": "J05AR09",
"display": "Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR09",
"display": "J05AR09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-01-28T00:00:00Z",
"display": "2013-01-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin, tenofovirdisoproksil, elvitegravir og kobicistat",
"language": "no"
} ]
}, {
"code": "J05AB16",
"display": "Remdesivir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB16",
"display": "J05AB16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-07-22T00:00:00Z",
"display": "2020-07-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Remdesivir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Remdesivir",
"language": "no"
} ]
}, {
"code": "J07AE51",
"display": "Cholera, combinations with typhoid vaccine, inactivated, whole cell",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Cholera vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AE51",
"display": "J07AE51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AE51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cholera, combinations with typhoid vaccine, inactivated, whole cell",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kolera, kombinasjoner med tyfoid vaksine, inaktivert, helcelle",
"language": "no"
} ]
}, {
"code": "J06BD08",
"display": "Nirsevimab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiviral monoclonal antibodies"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD08",
"display": "J06BD08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nirsevimab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nirsevimab",
"language": "no"
} ]
}, {
"code": "J01DD51",
"display": "Cefotaxime and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD51",
"display": "J01DD51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-02T00:00:00Z",
"display": "2018-01-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefotaxime and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefotaksim og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J05AE14",
"display": "Simeprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE14",
"display": "J05AE14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Simeprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Simeprevir",
"language": "no"
} ]
}, {
"code": "J01DF51",
"display": "Aztreonam and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Monobactams"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DF51",
"display": "J01DF51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-04-04T00:00:00Z",
"display": "2024-04-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DF51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Aztreonam and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aztreonam og betalaktamasehemmer",
"language": "no"
} ]
}, {
"code": "J01CF05",
"display": "Flucloxacillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase resistant penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CF05",
"display": "J01CF05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CF05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Flucloxacillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Flukloksacillin",
"language": "no"
} ]
}, {
"code": "J05AF12",
"display": "Clevudine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF12",
"display": "J05AF12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2009-03-20T00:00:00Z",
"display": "2009-03-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Clevudine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Klevudin",
"language": "no"
} ]
}, {
"code": "J01XE02",
"display": "Nifurtoinol",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nitrofuran derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XE02",
"display": "J01XE02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XE02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nifurtoinol",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nifurtoinol",
"language": "no"
} ]
}, {
"code": "J07AD01",
"display": "Brucella antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Brucellosis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AD01",
"display": "J07AD01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AD01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Brucella antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Brucellaantigen",
"language": "no"
} ]
}, {
"code": "J07BM01",
"display": "Papillomavirus (human types 6, 11, 16, 18)",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Papillomavirus vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BM01",
"display": "J07BM01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2006-09-29T00:00:00Z",
"display": "2006-09-29T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BM01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Papillomavirus (human types 6, 11, 16, 18)",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Papillomavirus (human type 6,11,16,18)",
"language": "no"
} ]
}, {
"code": "J01DC",
"display": "Second-generation cephalosporins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01D",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other beta-lactam antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC",
"display": "J01DC"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-20T00:00:00Z",
"display": "2014-11-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Second-generation cephalosporins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre generasjon cefalosporiner",
"language": "no"
} ]
}, {
"code": "J04B",
"display": "Drugs for treatment of lepra",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antimycobacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04B",
"display": "J04B"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04B"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Drugs for treatment of lepra",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Midler til behandling av lepra",
"language": "no"
} ]
}, {
"code": "J01RA09",
"display": "Ofloxacin and ornidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA09",
"display": "J01RA09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ofloxacin and ornidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ofloksacin og ornidazol",
"language": "no"
} ]
}, {
"code": "J01DD08",
"display": "Cefixime",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD08",
"display": "J01DD08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefixime",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefiksim",
"language": "no"
} ]
}, {
"code": "J01EA02",
"display": "Brodimoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Trimethoprim and derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EA02",
"display": "J01EA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Brodimoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Brodimoprim",
"language": "no"
} ]
}, {
"code": "J01GB04",
"display": "Kanamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB04",
"display": "J01GB04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Kanamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kanamycin",
"language": "no"
} ]
}, {
"code": "J07AH05",
"display": "Other meningococcal polyvalent purified polysaccharides antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH05",
"display": "J07AH05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other meningococcal polyvalent purified polysaccharides antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre meningokokk polyvalent renset polysakkarid antigen",
"language": "no"
} ]
}, {
"code": "J01XX11",
"display": "Tedizolid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX11",
"display": "J01XX11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tedizolid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tedizolid",
"language": "no"
} ]
}, {
"code": "J07BE01",
"display": "Mumps, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Mumps vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BE01",
"display": "J07BE01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BE01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Mumps, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kusma, levende, svekket",
"language": "no"
} ]
}, {
"code": "J01C",
"display": "Beta-lactam antibacterials, penicillins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01C",
"display": "J01C"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-02T00:00:00Z",
"display": "2014-10-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01C"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Beta-lactam antibacterials, penicillins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Beta-laktam antibakterielle midler, penicilliner",
"language": "no"
} ]
}, {
"code": "J05AE",
"display": "Protease inhibitors",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE",
"display": "J05AE"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Protease inhibitors",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Proteasehemmere",
"language": "no"
} ]
}, {
"code": "J04BA51",
"display": "Dapsone, rifampicin and clofazimine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of lepra"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04BA51",
"display": "J04BA51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04BA51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dapsone, rifampicin and clofazimine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dapson, rifampicin og klofazimin",
"language": "no"
} ]
}, {
"code": "J05AX67",
"display": "Ombitasvir, paritaprevir and ritonavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX67",
"display": "J05AX67"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-21T00:00:00Z",
"display": "2015-01-21T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX67"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ombitasvir, paritaprevir and ritonavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ombitasvir, paritaprevir og ritonavir",
"language": "no"
} ]
}, {
"code": "J05AR17",
"display": "Emtricitabine and tenofovir alafenamide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR17",
"display": "J05AR17"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR17"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine and tenofovir alafenamide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin og tenofoviralafenamid",
"language": "no"
} ]
}, {
"code": "J07BJ01",
"display": "Rubella, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Rubella vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BJ01",
"display": "J07BJ01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BJ01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rubella, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rubella, levende, svekket",
"language": "no"
} ]
}, {
"code": "J01DE",
"display": "Fourth-generation cephalosporins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01D",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other beta-lactam antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DE",
"display": "J01DE"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-22T00:00:00Z",
"display": "2014-10-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DE"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Fourth-generation cephalosporins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fjerde generasjon cefalasporiner",
"language": "no"
} ]
}, {
"code": "J01CE07",
"display": "Clometocillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE07",
"display": "J01CE07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-13T00:00:00Z",
"display": "2014-10-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Clometocillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Klometocillin",
"language": "no"
} ]
}, {
"code": "J07AL01",
"display": "Pneumococcus, purified polysaccharides antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AL",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Pneumococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AL01",
"display": "J07AL01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AL01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pneumococcus, purified polysaccharides antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pneumokokk, renset polysakkarid antigen",
"language": "no"
} ]
}, {
"code": "J01CA",
"display": "Penicillins with extended spectrum",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01C",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactam antibacterials, penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA",
"display": "J01CA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-19T00:00:00Z",
"display": "2014-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Penicillins with extended spectrum",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Penicilliner med utvidet spekter",
"language": "no"
} ]
}, {
"code": "J05AX",
"display": "Other antivirals",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX",
"display": "J05AX"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other antivirals",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre antivirale midler",
"language": "no"
} ]
}, {
"code": "J01AA01",
"display": "Demeclocycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA01",
"display": "J01AA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-29T00:00:00Z",
"display": "2015-01-29T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Demeclocycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Demeklosyklin",
"language": "no"
} ]
}, {
"code": "J06AA05",
"display": "Gas-gangrene sera",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immune sera"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06AA05",
"display": "J06AA05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06AA05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Gas-gangrene sera",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Gas-gangrenserum",
"language": "no"
} ]
}, {
"code": "J01DH02",
"display": "Meropenem",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Carbapenems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH02",
"display": "J01DH02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meropenem",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meropenem",
"language": "no"
} ]
}, {
"code": "J05AE30",
"display": "Nirmatrelvir and ritonavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE30",
"display": "J05AE30"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-02-01T00:00:00Z",
"display": "2022-02-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE30"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nirmatrelvir and ritonavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nirmatrelvir og ritonavir",
"language": "no"
} ]
}, {
"code": "J06BC03",
"display": "Bezlotoxumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterial monoclonal antibodies"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J06BB21",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bezlotoxumab"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BC03",
"display": "J06BC03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-02T00:00:00Z",
"display": "2021-12-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BC03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bezlotoxumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bezlotoksumab",
"language": "no"
} ]
}, {
"code": "J05AX29",
"display": "Fostemsavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX29",
"display": "J05AX29"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-10-12T00:00:00Z",
"display": "2020-10-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX29"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Fostemsavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fostemsavir",
"language": "no"
} ]
}, {
"code": "J01AA11",
"display": "Clomocycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA11",
"display": "J01AA11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-25T00:00:00Z",
"display": "2013-10-25T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Clomocycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Klomosyklin",
"language": "no"
} ]
}, {
"code": "J01DD09",
"display": "Cefodizime",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD09",
"display": "J01DD09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefodizime",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefodizim",
"language": "no"
} ]
}, {
"code": "J06BB09",
"display": "Cytomegalovirus immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB09",
"display": "J06BB09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cytomegalovirus immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot cytomegalovirus",
"language": "no"
} ]
}, {
"code": "J01RA17",
"display": "Ofloxacin and nitazoxanide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA17",
"display": "J01RA17"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA17"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ofloxacin and nitazoxanide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ofloksacin og nitazoksanid",
"language": "no"
} ]
}, {
"code": "J05AA01",
"display": "Metisazone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Thiosemicarbazones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AA01",
"display": "J05AA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Metisazone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Metisazon",
"language": "no"
} ]
}, {
"code": "J07C",
"display": "Bacterial and viral vaccines, combined",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07C",
"display": "J07C"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07C"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bacterial and viral vaccines, combined",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bakterie- og virusvaksiner, kombinert",
"language": "no"
} ]
}, {
"code": "J01EE06",
"display": "Sulfadiazine and tetroxoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of sulfonamides and trimethoprim, incl. derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EE06",
"display": "J01EE06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EE06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfadiazine and tetroxoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfadiazin og tetroksoprim",
"language": "no"
} ]
}, {
"code": "J01XX06",
"display": "Mandelic acid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX06",
"display": "J01XX06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-29T00:00:00Z",
"display": "2014-10-29T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Mandelic acid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Mandelsyre",
"language": "no"
} ]
}, {
"code": "J07BF04",
"display": "Poliomyelitis oral, bivalent, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Poliomyelitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BF04",
"display": "J07BF04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-01-28T00:00:00Z",
"display": "2013-01-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BF04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Poliomyelitis oral, bivalent, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Poliomyelitt oral, bivalent, levende svekket",
"language": "no"
} ]
}, {
"code": "J05AP10",
"display": "Elbasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP10",
"display": "J05AP10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Elbasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Elbasvir",
"language": "no"
} ]
}, {
"code": "J07BC",
"display": "Hepatitis vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BC",
"display": "J07BC"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BC"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Hepatitis vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Hepatittvaksiner",
"language": "no"
} ]
}, {
"code": "J07BN03",
"display": "Covid-19, inactivated virus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BN",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J07BX03",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BN03",
"display": "J07BN03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-15T00:00:00Z",
"display": "2021-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BN03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Covid-19, inactivated virus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Covid-19, inaktivert virus",
"language": "no"
} ]
}, {
"code": "J02AX08",
"display": "Rezafungin acetate",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AX08",
"display": "J02AX08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AX08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rezafungin acetate",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rezafunginacetat",
"language": "no"
} ]
}, {
"code": "J05AG01",
"display": "Nevirapine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Non-nucleoside reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AG01",
"display": "J05AG01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AG01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nevirapine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nevirapin",
"language": "no"
} ]
}, {
"code": "J07BX01",
"display": "Smallpox and monkeypox vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BX01",
"display": "J07BX01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-05-12T00:00:00Z",
"display": "2014-05-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BX01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Smallpox and monkeypox vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Koppe- og apekoppevaksiner",
"language": "no"
} ]
}, {
"code": "J01MA14",
"display": "Moxifloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA14",
"display": "J01MA14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Moxifloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Moksifloksacin",
"language": "no"
} ]
}, {
"code": "J05AB17",
"display": "Brincidofovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB17",
"display": "J05AB17"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB17"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Brincidofovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Brincidofovir",
"language": "no"
} ]
}, {
"code": "J05AX15",
"display": "Sofosbuvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX15",
"display": "J05AX15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-05-12T00:00:00Z",
"display": "2014-05-12T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir",
"language": "no"
} ]
}, {
"code": "J07CA10",
"display": "Typhoid-hepatitis A",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA10",
"display": "J07CA10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2005-04-05T00:00:00Z",
"display": "2005-04-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Typhoid-hepatitis A",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tyfoid-hepatitt A",
"language": "no"
} ]
}, {
"code": "J05AX02",
"display": "Lysozyme",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX02",
"display": "J05AX02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lysozyme",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lysozym",
"language": "no"
} ]
}, {
"code": "J01MA10",
"display": "Rufloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA10",
"display": "J01MA10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rufloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rufloksacin",
"language": "no"
} ]
}, {
"code": "J07AG01",
"display": "Haemophilus influenzae B, purified antigen conjugated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Haemophilus influenzae B vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AG01",
"display": "J07AG01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AG01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B, purified antigen conjugated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B, renset antigen konjugert",
"language": "no"
} ]
}, {
"code": "J07AP03",
"display": "Typhoid, purified polysaccharide antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Typhoid vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AP03",
"display": "J07AP03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AP03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Typhoid, purified polysaccharide antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tyfoid, renset polysakkarid antigen",
"language": "no"
} ]
}, {
"code": "J01ED20",
"display": "Combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED20",
"display": "J01ED20"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED20"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner",
"language": "no"
} ]
}, {
"code": "J01CA17",
"display": "Temocillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA17",
"display": "J01CA17"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA17"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Temocillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Temocillin",
"language": "no"
} ]
}, {
"code": "J05AH03",
"display": "Peramivir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Neuraminidase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AH03",
"display": "J05AH03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-03-12T00:00:00Z",
"display": "2018-03-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AH03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Peramivir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Peramivir",
"language": "no"
} ]
}, {
"code": "J05AR24",
"display": "Lamivudine, tenoforvir disoproxil and doravirine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR24",
"display": "J05AR24"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR24"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lamivudine, tenoforvir disoproxil and doravirine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lamivudin, tenofovirdisoproksil og doravirin",
"language": "no"
} ]
}, {
"code": "J01XX09",
"display": "Daptomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX09",
"display": "J01XX09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Daptomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Daptomycin",
"language": "no"
} ]
}, {
"code": "J05AE07",
"display": "Fosamprenavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE07",
"display": "J05AE07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2004-10-21T00:00:00Z",
"display": "2004-10-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Fosamprenavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fosamprenavir",
"language": "no"
} ]
}, {
"code": "J01MA04",
"display": "Enoxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA04",
"display": "J01MA04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Enoxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Enoksacin",
"language": "no"
} ]
}, {
"code": "J01DB12",
"display": "Ceftezole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB12",
"display": "J01DB12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftezole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftezol",
"language": "no"
} ]
}, {
"code": "J05AX26",
"display": "Amenamevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX26",
"display": "J05AX26"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX26"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Amenamevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Amenamevir",
"language": "no"
} ]
}, {
"code": "J01MA01",
"display": "Ofloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA01",
"display": "J01MA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ofloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ofloksacin",
"language": "no"
} ]
}, {
"code": "J01MA24",
"display": "Levonadifloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA24",
"display": "J01MA24"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-10-12T00:00:00Z",
"display": "2020-10-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA24"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Levonadifloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Levonadifloksacin",
"language": "no"
} ]
}, {
"code": "J01FA13",
"display": "Dirithromycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA13",
"display": "J01FA13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-17T00:00:00Z",
"display": "2014-10-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dirithromycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Diritromycin",
"language": "no"
} ]
}, {
"code": "J05AX01",
"display": "Moroxydine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX01",
"display": "J05AX01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Moroxydine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Moroksydin",
"language": "no"
} ]
}, {
"code": "J05AX28",
"display": "Bulevirtide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX28",
"display": "J05AX28"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-06-15T00:00:00Z",
"display": "2020-06-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX28"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bulevirtide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bulevirtid",
"language": "no"
} ]
}, {
"code": "J05AP04",
"display": "Faldaprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AE13",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Faldaprevir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP04",
"display": "J05AP04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Faldaprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Faldaprevir",
"language": "no"
} ]
}, {
"code": "J05AB",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB",
"display": "J05AB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nukleosider og nukleotider ekskl. reverstranskriptase-hemmere",
"language": "no"
} ]
}, {
"code": "J01AA56",
"display": "Oxytetracycline, combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA56",
"display": "J01AA56"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA56"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Oxytetracycline, combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Oksytetrasyklin, kombinasjoner",
"language": "no"
} ]
}, {
"code": "J05AR06",
"display": "Emtricitabine, tenofovir disoproxil and efavirenz",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR06",
"display": "J05AR06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine, tenofovir disoproxil and efavirenz",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin, tenofovirdisoproksil og efavirenz",
"language": "no"
} ]
}, {
"code": "J01MA13",
"display": "Trovafloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA13",
"display": "J01MA13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Trovafloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Trovafloksacin",
"language": "no"
} ]
}, {
"code": "J01GB10",
"display": "Ribostamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB10",
"display": "J01GB10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ribostamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ribostamycin",
"language": "no"
} ]
}, {
"code": "J01CA20",
"display": "Combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA20",
"display": "J01CA20"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA20"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner",
"language": "no"
} ]
}, {
"code": "J01DB09",
"display": "Cefradine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB09",
"display": "J01DB09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefradine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefradin",
"language": "no"
} ]
}, {
"code": "J01MA18",
"display": "Pazufloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA18",
"display": "J01MA18"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA18"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pazufloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pazufloksacin",
"language": "no"
} ]
}, {
"code": "J07",
"display": "Vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiinfectives for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07",
"display": "J07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Vaksiner",
"language": "no"
} ]
}, {
"code": "J07AN01",
"display": "Tuberculosis, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AN",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tuberculosis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AN01",
"display": "J07AN01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AN01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tuberculosis, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tuberkulose, levende, svekket",
"language": "no"
} ]
}, {
"code": "J01XD02",
"display": "Tinidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Imidazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XD02",
"display": "J01XD02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XD02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tinidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tinidazol",
"language": "no"
} ]
}, {
"code": "J05AG03",
"display": "Efavirenz",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Non-nucleoside reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AG03",
"display": "J05AG03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AG03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Efavirenz",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Efavirenz",
"language": "no"
} ]
}, {
"code": "J01MA19",
"display": "Garenoxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA19",
"display": "J01MA19"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA19"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Garenoxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Garenoksacin",
"language": "no"
} ]
}, {
"code": "J01CE04",
"display": "Azidocillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE04",
"display": "J01CE04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Azidocillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Azidocillin",
"language": "no"
} ]
}, {
"code": "J05AF08",
"display": "Adefovir dipivoxil",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF08",
"display": "J05AF08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2003-11-03T00:00:00Z",
"display": "2003-11-03T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Adefovir dipivoxil",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Adefovirdipivoksil",
"language": "no"
} ]
}, {
"code": "J07BB03",
"display": "Influenza, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Influenza vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BB03",
"display": "J07BB03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2009-03-20T00:00:00Z",
"display": "2009-03-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BB03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Influenza, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Influensa, levende, svekket",
"language": "no"
} ]
}, {
"code": "J07BX03",
"display": "Covid-19 vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BX03",
"display": "J07BX03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-01-06T00:00:00Z",
"display": "2021-01-06T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2023-01-13T00:00:00Z",
"display": "2023-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BX03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Covid-19 vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Covid-19 vaksiner",
"language": "no"
} ]
}, {
"code": "J01MA02",
"display": "Ciprofloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA02",
"display": "J01MA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ciprofloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ciprofloksacin",
"language": "no"
} ]
}, {
"code": "J07BN05",
"display": "Covid-19, virus-like particles",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BN",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BN05",
"display": "J07BN05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BN05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Covid-19, virus-like particles",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Covid-19, viruslignende partikler",
"language": "no"
} ]
}, {
"code": "J01XX13",
"display": "Gepotidacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX13",
"display": "J01XX13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Gepotidacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Gepotidacin",
"language": "no"
} ]
}, {
"code": "J01DC12",
"display": "Cefminox",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC12",
"display": "J01DC12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-14T00:00:00Z",
"display": "2011-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefminox",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefminoks",
"language": "no"
} ]
}, {
"code": "J07AR01",
"display": "Typhus exanthematicus, inactivated, whole cell",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Typhus (exanthematicus) vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AR01",
"display": "J07AR01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AR01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Typhus exanthematicus, inactivated, whole cell",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Typhus exanthematicus, inaktivert, helcelle",
"language": "no"
} ]
}, {
"code": "J05AP05",
"display": "Simeprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AE14",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Simeprevir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP05",
"display": "J05AP05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Simeprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Simeprevir",
"language": "no"
} ]
}, {
"code": "J07AG",
"display": "Haemophilus influenzae B vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AG",
"display": "J07AG"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AG"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B vaksiner",
"language": "no"
} ]
}, {
"code": "J02AB",
"display": "Imidazole derivatives",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AB",
"display": "J02AB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Imidazole derivatives",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Imidazolderivater",
"language": "no"
} ]
}, {
"code": "J01DC08",
"display": "Loracarbef",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC08",
"display": "J01DC08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-28T00:00:00Z",
"display": "2014-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Loracarbef",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lorakarbef",
"language": "no"
} ]
}, {
"code": "J05AR15",
"display": "Atazanavir and cobicistat",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR15",
"display": "J05AR15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Atazanavir and cobicistat",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Atazanavir og kobicistat",
"language": "no"
} ]
}, {
"code": "J02AX01",
"display": "Flucytosine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AX01",
"display": "J02AX01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AX01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Flucytosine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Flucytosin",
"language": "no"
} ]
}, {
"code": "J06BC02",
"display": "Raxibacumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterial monoclonal antibodies"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J06BB18",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Raxibacumab"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BC02",
"display": "J06BC02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-02T00:00:00Z",
"display": "2021-12-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BC02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Raxibacumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Raksibakumab",
"language": "no"
} ]
}, {
"code": "J05AE13",
"display": "Faldaprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE13",
"display": "J05AE13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Faldaprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Faldaprevir",
"language": "no"
} ]
}, {
"code": "J05AR10",
"display": "Lopinavir and ritonavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AE06",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Lopinavir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR10",
"display": "J05AR10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2012-12-21T00:00:00Z",
"display": "2012-12-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lopinavir and ritonavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lopinavir og ritonavir",
"language": "no"
} ]
}, {
"code": "J01CE08",
"display": "Benzathine benzylpenicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE08",
"display": "J01CE08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-07-18T00:00:00Z",
"display": "2014-07-18T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Benzathine benzylpenicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Benzatinbenzylpenicillin",
"language": "no"
} ]
}, {
"code": "J01XX05",
"display": "Methenamine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX05",
"display": "J01XX05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-29T00:00:00Z",
"display": "2014-10-29T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Methenamine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Metenamin",
"language": "no"
} ]
}, {
"code": "J01DH04",
"display": "Doripenem",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Carbapenems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH04",
"display": "J01DH04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Doripenem",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Doripenem",
"language": "no"
} ]
}, {
"code": "J01RA19",
"display": "Tetracycline and nystatin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA19",
"display": "J01RA19"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA19"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetracycline and nystatin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetrasyklin og nystatin",
"language": "no"
} ]
}, {
"code": "J01DE02",
"display": "Cefpirome",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fourth-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DE02",
"display": "J01DE02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DE02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefpirome",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefpirom",
"language": "no"
} ]
}, {
"code": "J07BC20",
"display": "Combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Hepatitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BC20",
"display": "J07BC20"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BC20"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner",
"language": "no"
} ]
}, {
"code": "J05AD01",
"display": "Foscarnet",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Phosphonic acid derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AD01",
"display": "J05AD01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AD01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Foscarnet",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Foskarnet",
"language": "no"
} ]
}, {
"code": "J01AA13",
"display": "Eravacycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA13",
"display": "J01AA13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-12-20T00:00:00Z",
"display": "2018-12-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Eravacycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Eravasyklin",
"language": "no"
} ]
}, {
"code": "J01FA03",
"display": "Midecamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA03",
"display": "J01FA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-30T00:00:00Z",
"display": "2014-10-30T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Midecamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Midekamycin",
"language": "no"
} ]
}, {
"code": "J01MA21",
"display": "Sitafloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA21",
"display": "J01MA21"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-12-16T00:00:00Z",
"display": "2010-12-16T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA21"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sitafloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sitafloksacin",
"language": "no"
} ]
}, {
"code": "J01XA01",
"display": "Vancomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Glycopeptide antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XA01",
"display": "J01XA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Vancomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Vankomycin",
"language": "no"
} ]
}, {
"code": "J01DF01",
"display": "Aztreonam",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Monobactams"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DF01",
"display": "J01DF01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DF01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Aztreonam",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aztreonam",
"language": "no"
} ]
}, {
"code": "J05AE02",
"display": "Indinavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE02",
"display": "J05AE02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Indinavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Indinavir",
"language": "no"
} ]
}, {
"code": "J04AM10",
"display": "Pyrazinamide, ethambutol, protionamide and lomefloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM10",
"display": "J04AM10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pyrazinamide, ethambutol, protionamide and lomefloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pyrazinamid, etambutol, protionamid og lomefloksacin",
"language": "no"
} ]
}, {
"code": "J01EE01",
"display": "Sulfamethoxazole and trimethoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of sulfonamides and trimethoprim, incl. derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EE01",
"display": "J01EE01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EE01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfamethoxazole and trimethoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfametoksazol og trimetoprim",
"language": "no"
} ]
}, {
"code": "J05AX07",
"display": "Enfuvirtide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX07",
"display": "J05AX07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2005-05-20T00:00:00Z",
"display": "2005-05-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Enfuvirtide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Enfuvirtid",
"language": "no"
} ]
}, {
"code": "J05AB04",
"display": "Ribavirin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB04",
"display": "J05AB04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ribavirin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ribavirin",
"language": "no"
} ]
}, {
"code": "J01R",
"display": "Combinations of antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01R",
"display": "J01R"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-14T00:00:00Z",
"display": "2014-10-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01R"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations of antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner av antibakterielle midler",
"language": "no"
} ]
}, {
"code": "J01RA06",
"display": "Cefepime and amikacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA06",
"display": "J01RA06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefepime and amikacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefepim og amikacin",
"language": "no"
} ]
}, {
"code": "J07AL02",
"display": "Pneumococcus, purified polysaccharides antigen conjugated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AL",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Pneumococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AL02",
"display": "J07AL02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AL02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pneumococcus, purified polysaccharides antigen conjugated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pneumokokk, renset polysakkarid antigen konjugert",
"language": "no"
} ]
}, {
"code": "J06BC",
"display": "Antibacterial monoclonal antibodies",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BC",
"display": "J06BC"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BC"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antibacterial monoclonal antibodies",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antibakterielle monoklonale antistoffer",
"language": "no"
} ]
}, {
"code": "J07AH10",
"display": "Meningococcus A, purified polysaccharides antigen conjugated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH10",
"display": "J07AH10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-01-28T00:00:00Z",
"display": "2013-01-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcus A, purified polysaccharides antigen conjugated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokk A, renset polysakkarid antigen konjugert",
"language": "no"
} ]
}, {
"code": "J04AB01",
"display": "Cycloserine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibiotics"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AB01",
"display": "J04AB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cycloserine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cykloserin",
"language": "no"
} ]
}, {
"code": "J01DF02",
"display": "Carumonam",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Monobactams"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DF02",
"display": "J01DF02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-14T00:00:00Z",
"display": "2011-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DF02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Carumonam",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Carumonam",
"language": "no"
} ]
}, {
"code": "J01MB07",
"display": "Flumequine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other quinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MB07",
"display": "J01MB07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MB07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Flumequine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Flumekin",
"language": "no"
} ]
}, {
"code": "J04AM04",
"display": "Thioacetazone and isoniazid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM04",
"display": "J04AM04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Thioacetazone and isoniazid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tioacetazon og isoniazid",
"language": "no"
} ]
}, {
"code": "J07BF03",
"display": "Poliomyelitis, trivalent, inactivated, whole virus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Poliomyelitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BF03",
"display": "J07BF03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BF03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Poliomyelitis, trivalent, inactivated, whole virus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Poliomyelitt, trivalent, inaktivert helvirus",
"language": "no"
} ]
}, {
"code": "J07BD53",
"display": "Measles, combinations with rubella, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Measles vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BD53",
"display": "J07BD53"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BD53"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Measles, combinations with rubella, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meslinger, kombinasjoner med rubella, levende svekket",
"language": "no"
} ]
}, {
"code": "J05AJ",
"display": "Integrase inhibitores",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AJ",
"display": "J05AJ"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-10-13T00:00:00Z",
"display": "2020-10-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AJ"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Integrase inhibitores",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Integrasehemmere",
"language": "no"
} ]
}, {
"code": "J05AP09",
"display": "Dasabuvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX16",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Dasabuvir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP09",
"display": "J05AP09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dasabuvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dasabuvir",
"language": "no"
} ]
}, {
"code": "J05AE11",
"display": "Telaprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE11",
"display": "J05AE11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-11-02T00:00:00Z",
"display": "2011-11-02T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Telaprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Telaprevir",
"language": "no"
} ]
}, {
"code": "J01MB05",
"display": "Oxolinic acid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other quinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MB05",
"display": "J01MB05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MB05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Oxolinic acid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Oksolinsyre",
"language": "no"
} ]
}, {
"code": "J01DD18",
"display": "Cefteram",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD18",
"display": "J01DD18"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-12-20T00:00:00Z",
"display": "2018-12-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD18"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefteram",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefteram",
"language": "no"
} ]
}, {
"code": "J06BB04",
"display": "Hepatitis B immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB04",
"display": "J06BB04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Hepatitis B immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot hepatitt B",
"language": "no"
} ]
}, {
"code": "J07CA07",
"display": "Diphtheria-hepatitis B-tetanus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA07",
"display": "J07CA07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-hepatitis B-tetanus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-hepatitt B-tetanus",
"language": "no"
} ]
}, {
"code": "J07BG01",
"display": "Rabies, inactivated, whole virus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Rabies vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BG01",
"display": "J07BG01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BG01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rabies, inactivated, whole virus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rabies, inaktivert, helvirus",
"language": "no"
} ]
}, {
"code": "J05AX05",
"display": "Inosine pranobex",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX05",
"display": "J05AX05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Inosine pranobex",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Inosin pranobeks",
"language": "no"
} ]
}, {
"code": "J07BB05",
"display": "Influenza, RNA-based vaccine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Influenza vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BB05",
"display": "J07BB05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BB05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Influenza, RNA-based vaccine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Influensa, RNA-basert vaksine",
"language": "no"
} ]
}, {
"code": "J06BA",
"display": "Immunoglobulins, normal human",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BA",
"display": "J06BA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Immunoglobulins, normal human",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin, normal human",
"language": "no"
} ]
}, {
"code": "J07BG",
"display": "Rabies vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BG",
"display": "J07BG"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BG"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rabies vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rabiesvaksiner",
"language": "no"
} ]
}, {
"code": "J05AX23",
"display": "Ibalizumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX23",
"display": "J05AX23"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX23"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ibalizumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ibalizumab",
"language": "no"
} ]
}, {
"code": "J05AP08",
"display": "Sofosbuvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX15",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Sofosbuvir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP08",
"display": "J05AP08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir",
"language": "no"
} ]
}, {
"code": "J01FA05",
"display": "Oleandomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA05",
"display": "J01FA05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Oleandomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Oleandomycin",
"language": "no"
} ]
}, {
"code": "J01FA10",
"display": "Azithromycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA10",
"display": "J01FA10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Azithromycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Azitromycin",
"language": "no"
} ]
}, {
"code": "J06BB22",
"display": "Obiltoxaximab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB22",
"display": "J06BB22"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-01-10T00:00:00Z",
"display": "2017-01-10T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2022-01-31T00:00:00Z",
"display": "2022-01-31T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB22"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Obiltoxaximab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Obiltoksaksimab",
"language": "no"
} ]
}, {
"code": "J01CA16",
"display": "Sulbenicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA16",
"display": "J01CA16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulbenicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulbenicillin",
"language": "no"
} ]
}, {
"code": "J01CF",
"display": "Beta-lactamase resistant penicillins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01C",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactam antibacterials, penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CF",
"display": "J01CF"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CF"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Beta-lactamase resistant penicillins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Beta-laktamaseresistente penicilliner",
"language": "no"
} ]
}, {
"code": "J05AE16",
"display": "Ensitrelvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE16",
"display": "J05AE16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2023-11-15T00:00:00Z",
"display": "2023-11-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ensitrelvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ensitrelvir",
"language": "no"
} ]
}, {
"code": "J01DD04",
"display": "Ceftriaxone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD04",
"display": "J01DD04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftriaxone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftriakson",
"language": "no"
} ]
}, {
"code": "J05AR16",
"display": "Lamivudine and raltegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR16",
"display": "J05AR16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lamivudine and raltegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lamivudin og raltegravir",
"language": "no"
} ]
}, {
"code": "J07AF",
"display": "Diphtheria vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AF",
"display": "J07AF"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AF"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difterivaksiner",
"language": "no"
} ]
}, {
"code": "J05AX32",
"display": "Riamilovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX32",
"display": "J05AX32"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX32"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Riamilovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Riamilovir",
"language": "no"
} ]
}, {
"code": "J07AP10",
"display": "Typhoid, combinations with paratyphi types",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Typhoid vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AP10",
"display": "J07AP10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AP10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Typhoid, combinations with paratyphi types",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tyfoid, kombinasjoner med paratyfoide varianter",
"language": "no"
} ]
}, {
"code": "J07BA",
"display": "Encephalitis vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BA",
"display": "J07BA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Encephalitis vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Encefalittvaksiner",
"language": "no"
} ]
}, {
"code": "J01CE30",
"display": "Combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE30",
"display": "J01CE30"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE30"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner",
"language": "no"
} ]
}, {
"code": "J07BE",
"display": "Mumps vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BE",
"display": "J07BE"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BE"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Mumps vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kusmavaksiner",
"language": "no"
} ]
}, {
"code": "J01EE07",
"display": "Sulfamerazine and trimethoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of sulfonamides and trimethoprim, incl. derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EE07",
"display": "J01EE07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EE07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfamerazine and trimethoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfamerazin og trimetoprim",
"language": "no"
} ]
}, {
"code": "J05A",
"display": "Direct acting antivirals",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05A",
"display": "J05A"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05A"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Direct acting antivirals",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Direktevirkende antivirale midler",
"language": "no"
} ]
}, {
"code": "J02AC01",
"display": "Fluconazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Triazole and tetrazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AC01",
"display": "J02AC01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AC01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Fluconazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Flukonazol",
"language": "no"
} ]
}, {
"code": "J07BL01",
"display": "Yellow fever, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BL",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Yellow fever vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BL01",
"display": "J07BL01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BL01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Yellow fever, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Gulfeber, levende, svekket",
"language": "no"
} ]
}, {
"code": "J05AX66",
"display": "Dasabuvir, ombitasvir, paritaprevir and ritonavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX66",
"display": "J05AX66"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX66"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dasabuvir, ombitasvir, paritaprevir and ritonavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dasabuvir, ombitasvir, paritaprevir og ritonavir",
"language": "no"
} ]
}, {
"code": "J07AN",
"display": "Tuberculosis vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AN",
"display": "J07AN"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AN"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tuberculosis vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tuberkulose vaksiner",
"language": "no"
} ]
}, {
"code": "J01AA09",
"display": "Rolitetracycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA09",
"display": "J01AA09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rolitetracycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rolitetrasyklin",
"language": "no"
} ]
}, {
"code": "J05AE12",
"display": "Boceprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE12",
"display": "J05AE12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-16T00:00:00Z",
"display": "2011-12-16T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Boceprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Boceprevir",
"language": "no"
} ]
}, {
"code": "J06BC04",
"display": "Obiltoxaximab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterial monoclonal antibodies"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J06BB22",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Obiltoxaximab"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BC04",
"display": "J06BC04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-02T00:00:00Z",
"display": "2021-12-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BC04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Obiltoxaximab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Obiltoxaksimab",
"language": "no"
} ]
}, {
"code": "J01XE03",
"display": "Furazidin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nitrofuran derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XE03",
"display": "J01XE03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XE03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Furazidin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Furazidin",
"language": "no"
} ]
}, {
"code": "J06BB06",
"display": "Rubella immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB06",
"display": "J06BB06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rubella immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot røde hunder",
"language": "no"
} ]
}, {
"code": "J06BB11",
"display": "Hepatitis A immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB11",
"display": "J06BB11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Hepatitis A immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot hepatitt A",
"language": "no"
} ]
}, {
"code": "J01GB05",
"display": "Neomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB05",
"display": "J01GB05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Neomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Neomycin",
"language": "no"
} ]
}, {
"code": "J05AG",
"display": "Non-nucleoside reverse transcriptase inhibitors",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AG",
"display": "J05AG"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AG"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Non-nucleoside reverse transcriptase inhibitors",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ikke-nukleosid reverstranskriptasehemmere",
"language": "no"
} ]
}, {
"code": "J05AH01",
"display": "Zanamivir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Neuraminidase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AH01",
"display": "J05AH01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AH01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Zanamivir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Zanamivir",
"language": "no"
} ]
}, {
"code": "J01ED09",
"display": "Sulfamazone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED09",
"display": "J01ED09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfamazone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfamazon",
"language": "no"
} ]
}, {
"code": "J01XX02",
"display": "Xibornol",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX02",
"display": "J01XX02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Xibornol",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Xibornol",
"language": "no"
} ]
}, {
"code": "J01CE10",
"display": "Benzathine phenoxymethylpenicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE10",
"display": "J01CE10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-08-18T00:00:00Z",
"display": "2020-08-18T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Benzathine phenoxymethylpenicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Benzatinfenoksymetylpenicillin",
"language": "no"
} ]
}, {
"code": "J07BJ",
"display": "Rubella vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BJ",
"display": "J07BJ"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BJ"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rubella vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rubellavaksiner",
"language": "no"
} ]
}, {
"code": "J06A",
"display": "Immune sera",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immune sera and immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06A",
"display": "J06A"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06A"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Immune sera",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunsera",
"language": "no"
} ]
}, {
"code": "J01EB08",
"display": "Sulfathiourea",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Short-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB08",
"display": "J01EB08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfathiourea",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfatiourea",
"language": "no"
} ]
}, {
"code": "J01FG01",
"display": "Pristinamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Streptogramins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FG01",
"display": "J01FG01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FG01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pristinamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pristinamycin",
"language": "no"
} ]
}, {
"code": "J04AC51",
"display": "Isoniazid, combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Hydrazides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AC51",
"display": "J04AC51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AC51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Isoniazid, combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Isoniazid, kombinasjoner",
"language": "no"
} ]
}, {
"code": "J05AX24",
"display": "Tecovirimat",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX24",
"display": "J05AX24"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX24"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tecovirimat",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tekovirimat",
"language": "no"
} ]
}, {
"code": "J07BF",
"display": "Poliomyelitis vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BF",
"display": "J07BF"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BF"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Poliomyelitis vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Poliomyelittvaksiner",
"language": "no"
} ]
}, {
"code": "J07BP",
"display": "Chikungunya vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BP",
"display": "J07BP"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2025-06-02T00:00:00Z",
"display": "2025-06-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BP"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Chikungunya vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Chikungunyavaksiner",
"language": "no"
} ]
}, {
"code": "J07AC",
"display": "Anthrax vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AC",
"display": "J07AC"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AC"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Anthrax vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antraksvaksiner",
"language": "no"
} ]
}, {
"code": "J05",
"display": "Antivirals for systemic use",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiinfectives for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05",
"display": "J05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antivirals for systemic use",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antivirale midler til systemisk bruk",
"language": "no"
} ]
}, {
"code": "J01EC",
"display": "Intermediate-acting sulfonamides",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01E",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Sulfonamides and trimethoprim"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EC",
"display": "J01EC"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EC"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Intermediate-acting sulfonamides",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfonamider med middels lang virketid",
"language": "no"
} ]
}, {
"code": "J04AA02",
"display": "Sodium aminosalicylate",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Aminosalicylic acid and derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AA02",
"display": "J04AA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sodium aminosalicylate",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aminosalisylatnatrium",
"language": "no"
} ]
}, {
"code": "J01DI02",
"display": "Ceftaroline fosamil",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DI",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other cephalosporins and penems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DI02",
"display": "J01DI02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-12-15T00:00:00Z",
"display": "2010-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DI02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftaroline fosamil",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftarolinfosamil",
"language": "no"
} ]
}, {
"code": "J01MA06",
"display": "Norfloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA06",
"display": "J01MA06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Norfloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Norfloksacin",
"language": "no"
} ]
}, {
"code": "J01EB07",
"display": "Sulfathiazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Short-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB07",
"display": "J01EB07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfathiazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfatiazol",
"language": "no"
} ]
}, {
"code": "J01XA",
"display": "Glycopeptide antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01X",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XA",
"display": "J01XA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-22T00:00:00Z",
"display": "2014-10-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Glycopeptide antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Glykopeptid antibakterielle midler",
"language": "no"
} ]
}, {
"code": "J05AR13",
"display": "Lamivudine, abacavir and dolutegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR13",
"display": "J05AR13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-30T00:00:00Z",
"display": "2013-10-30T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lamivudine, abacavir and dolutegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lamivudin, abakavir og dolutegravir",
"language": "no"
} ]
}, {
"code": "J07CA02",
"display": "Diphtheria-pertussis-poliomyelitis-tetanus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA02",
"display": "J07CA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-pertussis-poliomyelitis-tetanus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-kikhoste-poliomyelitt-tetanus",
"language": "no"
} ]
}, {
"code": "J01CR05",
"display": "Piperacillin and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of penicillins, incl. beta-lactamase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CR05",
"display": "J01CR05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-12-01T00:00:00Z",
"display": "2020-12-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CR05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Piperacillin and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Piperacillin og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J05AX10",
"display": "Maribavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX10",
"display": "J05AX10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Maribavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Maribavir",
"language": "no"
} ]
}, {
"code": "J04AD",
"display": "Thiocarbamide derivatives",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AD",
"display": "J04AD"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AD"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Thiocarbamide derivatives",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tiokarbamidderivater",
"language": "no"
} ]
}, {
"code": "J07A",
"display": "Bacterial vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07A",
"display": "J07A"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07A"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bacterial vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bakterievaksiner",
"language": "no"
} ]
}, {
"code": "J04BA02",
"display": "Dapsone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of lepra"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04BA02",
"display": "J04BA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04BA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dapsone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dapson",
"language": "no"
} ]
}, {
"code": "J05AR22",
"display": "Emtricitabine, tenofovir alafenamide, darunavir and cobicistat",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR22",
"display": "J05AR22"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-12-01T00:00:00Z",
"display": "2017-12-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR22"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine, tenofovir alafenamide, darunavir and cobicistat",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin, tenofoviralafenamid, darunavir og kobicistat",
"language": "no"
} ]
}, {
"code": "J01EB02",
"display": "Sulfamethizole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Short-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB02",
"display": "J01EB02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfamethizole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfametizol",
"language": "no"
} ]
}, {
"code": "J01MA",
"display": "Fluoroquinolones",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01M",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Quinolone antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA",
"display": "J01MA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-22T00:00:00Z",
"display": "2014-10-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Fluoroquinolones",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fluorokinoloner",
"language": "no"
} ]
}, {
"code": "J07BK03",
"display": "Zoster. purified antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Varicella zoster vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BK03",
"display": "J07BK03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-01-12T00:00:00Z",
"display": "2017-01-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BK03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Zoster. purified antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Zoster, renset antigen",
"language": "no"
} ]
}, {
"code": "J07CA09",
"display": "Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA09",
"display": "J07CA09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-haemophilus influenzae B-kikhoste-poliomyelitt-tetanus-hepatitt B",
"language": "no"
} ]
}, {
"code": "J01EE02",
"display": "Sulfadiazine and trimethoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of sulfonamides and trimethoprim, incl. derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EE02",
"display": "J01EE02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-21T00:00:00Z",
"display": "2014-11-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EE02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfadiazine and trimethoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfadiazin og trimetoprim",
"language": "no"
} ]
}, {
"code": "J01GA01",
"display": "Streptomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Streptomycins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GA01",
"display": "J01GA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Streptomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Streptomycin",
"language": "no"
} ]
}, {
"code": "J01GB03",
"display": "Gentamicin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB03",
"display": "J01GB03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Gentamicin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Gentamicin",
"language": "no"
} ]
}, {
"code": "J06AA06",
"display": "Rabies serum",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immune sera"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06AA06",
"display": "J06AA06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06AA06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rabies serum",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rabiesserum",
"language": "no"
} ]
}, {
"code": "J01XC01",
"display": "Fusidic acid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Steroid antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XC01",
"display": "J01XC01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XC01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Fusidic acid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fusidinsyre",
"language": "no"
} ]
}, {
"code": "J07AP",
"display": "Typhoid vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AP",
"display": "J07AP"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AP"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Typhoid vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tyfoidvaksiner",
"language": "no"
} ]
}, {
"code": "J07CA03",
"display": "Diphtheria-rubella-tetanus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA03",
"display": "J07CA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-rubella-tetanus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-rubella-tetanus",
"language": "no"
} ]
}, {
"code": "J01DD62",
"display": "Cefoperazone and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD62",
"display": "J01DD62"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-02T00:00:00Z",
"display": "2018-01-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD62"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefoperazone and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefoperazon og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J07CA11",
"display": "Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA11",
"display": "J07CA11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-01-01T00:00:00Z",
"display": "2007-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-haemophilus influenzae B-kikhoste-tetanus-hepatitt B",
"language": "no"
} ]
}, {
"code": "J06BD05",
"display": "Sotrovimab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiviral monoclonal antibodies"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD05",
"display": "J06BD05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-13T00:00:00Z",
"display": "2021-12-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sotrovimab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sotrovimab",
"language": "no"
} ]
}, {
"code": "J01DD06",
"display": "Latamoxef",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD06",
"display": "J01DD06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-25T00:00:00Z",
"display": "2013-10-25T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Latamoxef",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Latamoksef",
"language": "no"
} ]
}, {
"code": "J06BB08",
"display": "Staphylococcus immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB08",
"display": "J06BB08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Staphylococcus immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot stafylokokker",
"language": "no"
} ]
}, {
"code": "J07BJ51",
"display": "Rubella, combinations with mumps, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Rubella vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BJ51",
"display": "J07BJ51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BJ51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rubella, combinations with mumps, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rubella, kombinert med kusma, levende svekket",
"language": "no"
} ]
}, {
"code": "J01CG01",
"display": "Sulbactam",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CG01",
"display": "J01CG01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-21T00:00:00Z",
"display": "2014-11-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CG01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulbactam",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulbaktam",
"language": "no"
} ]
}, {
"code": "J01CE01",
"display": "Benzylpenicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE01",
"display": "J01CE01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Benzylpenicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Benzylpenicillin",
"language": "no"
} ]
}, {
"code": "J01MB01",
"display": "Rosoxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other quinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MB01",
"display": "J01MB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rosoxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rosoksacin",
"language": "no"
} ]
}, {
"code": "J01AA",
"display": "Tetracyclines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA",
"display": "J01AA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetracyclines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetrasykliner",
"language": "no"
} ]
}, {
"code": "J01CR02",
"display": "Amoxicillin and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of penicillins, incl. beta-lactamase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CR02",
"display": "J01CR02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-02T00:00:00Z",
"display": "2018-01-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CR02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Amoxicillin and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Amoksicillin og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J01ED06",
"display": "Sulfaperin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED06",
"display": "J01ED06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfaperin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfaperin",
"language": "no"
} ]
}, {
"code": "J01CR50",
"display": "Combinations of penicillins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of penicillins, incl. beta-lactamase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CR50",
"display": "J01CR50"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-14T00:00:00Z",
"display": "2014-10-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CR50"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations of penicillins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner av penicilliner",
"language": "no"
} ]
}, {
"code": "J07AJ51",
"display": "Pertussis, inactivated, whole cell, combinations with toxoids",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Pertussis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AJ51",
"display": "J07AJ51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AJ51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pertussis, inactivated, whole cell, combinations with toxoids",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kikhoste, inaktivert, helcelle, kombinasjoner med toksoider",
"language": "no"
} ]
}, {
"code": "J06BC01",
"display": "Nebacumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterial monoclonal antibodies"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BC01",
"display": "J06BC01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BC01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nebacumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nebakumab",
"language": "no"
} ]
}, {
"code": "J07AH02",
"display": "Other meningococcal monovalent purified polysaccharides antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH02",
"display": "J07AH02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other meningococcal monovalent purified polysaccharides antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre meningokokk monovalent, renset polysakkarid antigen",
"language": "no"
} ]
}, {
"code": "J05AE10",
"display": "Darunavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE10",
"display": "J05AE10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2006-02-13T00:00:00Z",
"display": "2006-02-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Darunavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Darunavir",
"language": "no"
} ]
}, {
"code": "J04AD01",
"display": "Protionamide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Thiocarbamide derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AD01",
"display": "J04AD01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AD01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Protionamide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Protionamid",
"language": "no"
} ]
}, {
"code": "J01CA10",
"display": "Mezlocillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA10",
"display": "J01CA10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Mezlocillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Mezlocillin",
"language": "no"
} ]
}, {
"code": "J07BH01",
"display": "Rota virus, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Rota virus diarrhea vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BH01",
"display": "J07BH01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BH01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rota virus, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rotavirus, levende, svekket",
"language": "no"
} ]
}, {
"code": "J05AE05",
"display": "Amprenavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE05",
"display": "J05AE05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Amprenavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Amprenavir",
"language": "no"
} ]
}, {
"code": "J02AB02",
"display": "Ketoconazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Imidazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AB02",
"display": "J02AB02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AB02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ketoconazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ketokonazol",
"language": "no"
} ]
}, {
"code": "J01CA19",
"display": "Aspoxicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA19",
"display": "J01CA19"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-14T00:00:00Z",
"display": "2011-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA19"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Aspoxicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aspoksicillin",
"language": "no"
} ]
}, {
"code": "J01RA12",
"display": "Ciprofloxacin and ornidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA12",
"display": "J01RA12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ciprofloxacin and ornidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ciprofloksacin og ornidazol",
"language": "no"
} ]
}, {
"code": "J05AP51",
"display": "Sofosbuvir and ledipasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX65",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Sofosbuvir and ledipasvir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP51",
"display": "J05AP51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir and ledipasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir og ledipasvir",
"language": "no"
} ]
}, {
"code": "J04AC02",
"display": "Ftivazide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Hydrazides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AC02",
"display": "J04AC02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AC02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ftivazide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ftivazid",
"language": "no"
} ]
}, {
"code": "J07BH02",
"display": "Rota virus, pentavalent, live, reassorted",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Rota virus diarrhea vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BH02",
"display": "J07BH02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BH02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rota virus, pentavalent, live, reassorted",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rotavirus, femverdig, levende, assorterte",
"language": "no"
} ]
}, {
"code": "J01MA09",
"display": "Sparfloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA09",
"display": "J01MA09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sparfloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sparfloksacin",
"language": "no"
} ]
}, {
"code": "J06BA01",
"display": "Immunoglobulins, normal human, for extravascular adm.",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immunoglobulins, normal human"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BA01",
"display": "J06BA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Immunoglobulins, normal human, for extravascular adm.",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin, normal human, til ekstravaskulær adm",
"language": "no"
} ]
}, {
"code": "J05AX19",
"display": "Tilorone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX19",
"display": "J05AX19"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX19"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tilorone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tiloron",
"language": "no"
} ]
}, {
"code": "J02AX05",
"display": "Micafungin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AX05",
"display": "J02AX05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2003-04-24T00:00:00Z",
"display": "2003-04-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AX05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Micafungin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Mikafungin",
"language": "no"
} ]
}, {
"code": "J05AC03",
"display": "Tromantadine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Cyclic amines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AC03",
"display": "J05AC03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AC03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tromantadine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tromantadin",
"language": "no"
} ]
}, {
"code": "J01E",
"display": "Sulfonamides and trimethoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01E",
"display": "J01E"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-21T00:00:00Z",
"display": "2014-11-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01E"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfonamides and trimethoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfonamider og trimetoprim",
"language": "no"
} ]
}, {
"code": "J05AP13",
"display": "Ravidasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP13",
"display": "J05AP13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2023-11-15T00:00:00Z",
"display": "2023-11-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ravidasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ravidasvir",
"language": "no"
} ]
}, {
"code": "J05AD02",
"display": "Fosfonet",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Phosphonic acid derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AD02",
"display": "J05AD02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AD02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Fosfonet",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fosfonet",
"language": "no"
} ]
}, {
"code": "J01DC11",
"display": "Ceforanide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC11",
"display": "J01DC11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceforanide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceforanid",
"language": "no"
} ]
}, {
"code": "J05AB01",
"display": "Aciclovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB01",
"display": "J05AB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Aciclovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aciklovir",
"language": "no"
} ]
}, {
"code": "J07AC01",
"display": "Anthrax antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Anthrax vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AC01",
"display": "J07AC01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AC01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Anthrax antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antraksantigen",
"language": "no"
} ]
}, {
"code": "J07CA08",
"display": "Haemophilus influenzae B and hepatitis B",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA08",
"display": "J07CA08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B and hepatitis B",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B og hepatitt B",
"language": "no"
} ]
}, {
"code": "J04",
"display": "Antimycobacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiinfectives for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04",
"display": "J04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antimycobacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antimykobakterielle midler",
"language": "no"
} ]
}, {
"code": "J04BA",
"display": "Drugs for treatment of lepra",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of lepra"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04BA",
"display": "J04BA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04BA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Drugs for treatment of lepra",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Midler til behandling av lepra",
"language": "no"
} ]
}, {
"code": "J04AC",
"display": "Hydrazides",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AC",
"display": "J04AC"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AC"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Hydrazides",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Hydrazider",
"language": "no"
} ]
}, {
"code": "J06BB30",
"display": "Combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB30",
"display": "J06BB30"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB30"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner",
"language": "no"
} ]
}, {
"code": "J01DD13",
"display": "Cefpodoxime",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD13",
"display": "J01DD13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-06-07T00:00:00Z",
"display": "2010-06-07T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefpodoxime",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefpodoksim",
"language": "no"
} ]
}, {
"code": "J01X",
"display": "Other antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01X",
"display": "J01X"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-12T00:00:00Z",
"display": "2014-11-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01X"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre antibakterielle midler",
"language": "no"
} ]
}, {
"code": "J07AM52",
"display": "Tetanus toxoid, combinations with tetanus immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetanus vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AM52",
"display": "J07AM52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AM52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetanus toxoid, combinations with tetanus immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetanustoksoid, kombinasjoner med tetanus immunglobulin",
"language": "no"
} ]
}, {
"code": "J01DC14",
"display": "Flomoxef",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC14",
"display": "J01DC14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-14T00:00:00Z",
"display": "2011-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Flomoxef",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Flomoksef",
"language": "no"
} ]
}, {
"code": "J01RA11",
"display": "Ciprofloxacin and tinidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA11",
"display": "J01RA11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-03-22T00:00:00Z",
"display": "2017-03-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ciprofloxacin and tinidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ciprofloksacin og tinidazol",
"language": "no"
} ]
}, {
"code": "J05AX17",
"display": "Enisamium iodide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX17",
"display": "J05AX17"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX17"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Enisamium iodide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Enisamiumjodid",
"language": "no"
} ]
}, {
"code": "J02AC06",
"display": "Oteseconazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Triazole and tetrazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AC06",
"display": "J02AC06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-03-04T00:00:00Z",
"display": "2021-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AC06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Oteseconazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Otesekonazol",
"language": "no"
} ]
}, {
"code": "J02AC04",
"display": "Posaconazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Triazole and tetrazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AC04",
"display": "J02AC04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2005-11-25T00:00:00Z",
"display": "2005-11-25T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AC04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Posaconazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Posakonazol",
"language": "no"
} ]
}, {
"code": "J01ED03",
"display": "Sulfametomidine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED03",
"display": "J01ED03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfametomidine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfametomidin",
"language": "no"
} ]
}, {
"code": "J06AA03",
"display": "Snake venom antiserum",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immune sera"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06AA03",
"display": "J06AA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06AA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Snake venom antiserum",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Slangegiftantiserum",
"language": "no"
} ]
}, {
"code": "J01DC05",
"display": "Cefotetan",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC05",
"display": "J01DC05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefotetan",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefotetan",
"language": "no"
} ]
}, {
"code": "J07AX01",
"display": "Leptospira vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AX01",
"display": "J07AX01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AX01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Leptospira vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Leptospiravaksiner",
"language": "no"
} ]
}, {
"code": "J04AA",
"display": "Aminosalicylic acid and derivatives",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AA",
"display": "J04AA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Aminosalicylic acid and derivatives",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aminosalisylsyre og derivater",
"language": "no"
} ]
}, {
"code": "J07AJ02",
"display": "Pertussis, purified antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Pertussis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AJ02",
"display": "J07AJ02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AJ02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pertussis, purified antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kikhoste, renset antigen",
"language": "no"
} ]
}, {
"code": "J01DD54",
"display": "Ceftriaxone, combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD54",
"display": "J01DD54"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-06-07T00:00:00Z",
"display": "2010-06-07T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD54"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftriaxone, combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftriakson, kombinasjoner",
"language": "no"
} ]
}, {
"code": "J07AH",
"display": "Meningococcal vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH",
"display": "J07AH"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcal vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokkvaksiner",
"language": "no"
} ]
}, {
"code": "J07BC01",
"display": "Hepatitis B, purified antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Hepatitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BC01",
"display": "J07BC01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BC01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Hepatitis B, purified antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Hepatitt B, renset antigen",
"language": "no"
} ]
}, {
"code": "J06BD07",
"display": "Casirivimab and imdevimab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiviral monoclonal antibodies"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD07",
"display": "J06BD07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-15T00:00:00Z",
"display": "2021-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Casirivimab and imdevimab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kasirivimab og imdevimab",
"language": "no"
} ]
}, {
"code": "J07BN02",
"display": "Covid-19, viral vector, non-replicating",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BN",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J07BX03",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BN02",
"display": "J07BN02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-15T00:00:00Z",
"display": "2021-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BN02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Covid-19, viral vector, non-replicating",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Covid-19, viral vektor, ikke-replikerende",
"language": "no"
} ]
}, {
"code": "J01RA02",
"display": "Sulfonamides, combinations with other antibacterials (excl. trimethoprim)",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA02",
"display": "J01RA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfonamides, combinations with other antibacterials (excl. trimethoprim)",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfonamider, kombinasjoner med andre antibakterielle midler ekskl. trimetoprim",
"language": "no"
} ]
}, {
"code": "J01F",
"display": "Macrolides, lincosamides and streptogramins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01F",
"display": "J01F"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-28T00:00:00Z",
"display": "2014-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01F"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Macrolides, lincosamides and streptogramins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Makrolider, linkosamider og streptograminer",
"language": "no"
} ]
}, {
"code": "J01EC01",
"display": "Sulfamethoxazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Intermediate-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EC01",
"display": "J01EC01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EC01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfamethoxazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfametoksazol",
"language": "no"
} ]
}, {
"code": "J01GB07",
"display": "Netilmicin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB07",
"display": "J01GB07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Netilmicin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Netilmicin",
"language": "no"
} ]
}, {
"code": "J01DD15",
"display": "Cefdinir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD15",
"display": "J01DD15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefdinir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefdinir",
"language": "no"
} ]
}, {
"code": "J05AX69",
"display": "Sofosbuvir and velpatasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX69",
"display": "J05AX69"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-01-03T00:00:00Z",
"display": "2017-01-03T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX69"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir and velpatasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir og velpatasvir",
"language": "no"
} ]
}, {
"code": "J01GB13",
"display": "Bekanamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB13",
"display": "J01GB13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-14T00:00:00Z",
"display": "2011-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bekanamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bekanamycin",
"language": "no"
} ]
}, {
"code": "J01DC06",
"display": "Cefonicide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC06",
"display": "J01DC06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefonicide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefonicid",
"language": "no"
} ]
}, {
"code": "J01EB04",
"display": "Sulfapyridine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Short-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB04",
"display": "J01EB04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfapyridine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfapyridin",
"language": "no"
} ]
}, {
"code": "J04AM02",
"display": "Rifampicin and isoniazid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM02",
"display": "J04AM02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifampicin and isoniazid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifampicin og isoniazid",
"language": "no"
} ]
}, {
"code": "J05AB18",
"display": "Molnupiravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB18",
"display": "J05AB18"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB18"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Molnupiravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Molnupiravir",
"language": "no"
} ]
}, {
"code": "J02AX06",
"display": "Anidulafungin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AX06",
"display": "J02AX06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AX06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Anidulafungin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Anidulafungin",
"language": "no"
} ]
}, {
"code": "J05AJ02",
"display": "Elvitegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Integrase inhibitores"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX11",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Elvitegravir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AJ02",
"display": "J05AJ02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-12-14T00:00:00Z",
"display": "2020-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AJ02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Elvitegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Elvitegravir",
"language": "no"
} ]
}, {
"code": "J07BN",
"display": "Covid-19 vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J07BX03",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BN",
"display": "J07BN"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-15T00:00:00Z",
"display": "2021-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BN"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Covid-19 vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Covid-19-vaksiner",
"language": "no"
} ]
}, {
"code": "J07AM01",
"display": "Tetanus toxoid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetanus vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AM01",
"display": "J07AM01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AM01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetanus toxoid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetanustoksoid",
"language": "no"
} ]
}, {
"code": "J02AX",
"display": "Other antimycotics for systemic use",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AX",
"display": "J02AX"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AX"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other antimycotics for systemic use",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre antimykotika til systemisk bruk",
"language": "no"
} ]
}, {
"code": "J05AB14",
"display": "Valganciclovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB14",
"display": "J05AB14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2003-02-12T00:00:00Z",
"display": "2003-02-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Valganciclovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Valganciklovir",
"language": "no"
} ]
}, {
"code": "J01FA14",
"display": "Flurithromycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA14",
"display": "J01FA14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-22T00:00:00Z",
"display": "2014-10-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Flurithromycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fluritromycin",
"language": "no"
} ]
}, {
"code": "J01DC02",
"display": "Cefuroxime",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC02",
"display": "J01DC02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefuroxime",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefuroksim",
"language": "no"
} ]
}, {
"code": "J05AA",
"display": "Thiosemicarbazones",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AA",
"display": "J05AA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Thiosemicarbazones",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tiosemikarbazoner",
"language": "no"
} ]
}, {
"code": "J07AP02",
"display": "Typhoid, inactivated, whole cell",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Typhoid vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AP02",
"display": "J07AP02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AP02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Typhoid, inactivated, whole cell",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tyfoid, inaktivert, helcelle",
"language": "no"
} ]
}, {
"code": "J01DD07",
"display": "Ceftizoxime",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD07",
"display": "J01DD07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-06-07T00:00:00Z",
"display": "2010-06-07T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftizoxime",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftizoksim",
"language": "no"
} ]
}, {
"code": "J01DD",
"display": "Third-generation cephalosporins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01D",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other beta-lactam antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD",
"display": "J01DD"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Third-generation cephalosporins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tredje generasjon cefalosporiner",
"language": "no"
} ]
}, {
"code": "J02AA02",
"display": "Hachimycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibiotics"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AA02",
"display": "J02AA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Hachimycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Hakimycin",
"language": "no"
} ]
}, {
"code": "J01CA14",
"display": "Metampicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA14",
"display": "J01CA14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Metampicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Metampicillin",
"language": "no"
} ]
}, {
"code": "J07CA04",
"display": "Haemophilus influenzae B and poliomyelitis",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA04",
"display": "J07CA04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B and poliomyelitis",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B og poliomyelitt",
"language": "no"
} ]
}, {
"code": "J01XE51",
"display": "Nitrofurantoin, combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nitrofuran derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XE51",
"display": "J01XE51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XE51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nitrofurantoin, combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nitrofurantoin, kombinasjoner",
"language": "no"
} ]
}, {
"code": "J01RA16",
"display": "Cefixime and azithromycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA16",
"display": "J01RA16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefixime and azithromycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefiksim og azitromycin",
"language": "no"
} ]
}, {
"code": "J",
"display": "Antiinfectives for systemic use",
"property": [ {
"code": "ATCCode",
"valueCoding": {
"code": "J",
"display": "J"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antiinfectives for systemic use",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antiinfektiva til systemisk bruk",
"language": "no"
} ]
}, {
"code": "J05AR12",
"display": "Lamivudine and tenofovir disoproxil",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR12",
"display": "J05AR12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lamivudine and tenofovir disoproxil",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lamivudin og tenofovirdisoproksil",
"language": "no"
} ]
}, {
"code": "J06BB21",
"display": "Bezlotoxumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB21",
"display": "J06BB21"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-01-10T00:00:00Z",
"display": "2017-01-10T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2022-01-31T00:00:00Z",
"display": "2022-01-31T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB21"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bezlotoxumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bezlotoksumab",
"language": "no"
} ]
}, {
"code": "J01XA05",
"display": "Oritavancin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Glycopeptide antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XA05",
"display": "J01XA05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-13T00:00:00Z",
"display": "2010-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XA05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Oritavancin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Oritavancin",
"language": "no"
} ]
}, {
"code": "J01EC02",
"display": "Sulfadiazine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Intermediate-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EC02",
"display": "J01EC02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EC02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfadiazine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfadiazin",
"language": "no"
} ]
}, {
"code": "J01XA04",
"display": "Dalbavancin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Glycopeptide antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XA04",
"display": "J01XA04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-13T00:00:00Z",
"display": "2010-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XA04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dalbavancin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dalbavancin",
"language": "no"
} ]
}, {
"code": "J01DH03",
"display": "Ertapenem",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Carbapenems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH03",
"display": "J01DH03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ertapenem",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ertapenem",
"language": "no"
} ]
}, {
"code": "J01FA06",
"display": "Roxithromycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA06",
"display": "J01FA06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Roxithromycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Roksitromycin",
"language": "no"
} ]
}, {
"code": "J05AX16",
"display": "Dasabuvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX16",
"display": "J05AX16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dasabuvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dasabuvir",
"language": "no"
} ]
}, {
"code": "J01RA18",
"display": "Ofloxacin and tinidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA18",
"display": "J01RA18"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA18"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ofloxacin and tinidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ofloksacin og tinidazol",
"language": "no"
} ]
}, {
"code": "J01DD05",
"display": "Cefmenoxime",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD05",
"display": "J01DD05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-06-07T00:00:00Z",
"display": "2010-06-07T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefmenoxime",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefmenoksim",
"language": "no"
} ]
}, {
"code": "J05AR14",
"display": "Darunavir and cobicistat",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR14",
"display": "J05AR14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Darunavir and cobicistat",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Darunavir og kobicistat",
"language": "no"
} ]
}, {
"code": "J07BP01",
"display": "Chikungunya, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Chikungunya vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BP01",
"display": "J07BP01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2025-06-02T00:00:00Z",
"display": "2025-06-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BP01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Chikungunya, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Chikungunya, levende, attenuert",
"language": "no"
} ]
}, {
"code": "J07AD",
"display": "Brucellosis vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AD",
"display": "J07AD"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AD"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Brucellosis vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Brucellosisvaksiner",
"language": "no"
} ]
}, {
"code": "J05AF11",
"display": "Telbivudine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF11",
"display": "J05AF11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Telbivudine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Telbivudin",
"language": "no"
} ]
}, {
"code": "J01RA08",
"display": "Tetracycline and oleandomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA08",
"display": "J01RA08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetracycline and oleandomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetrasyklin og oleandomycin",
"language": "no"
} ]
}, {
"code": "J01CR03",
"display": "Ticarcillin and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of penicillins, incl. beta-lactamase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CR03",
"display": "J01CR03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-02T00:00:00Z",
"display": "2018-01-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CR03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ticarcillin and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tikarcillin og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J01BA01",
"display": "Chloramphenicol",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Amphenicols"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01BA01",
"display": "J01BA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01BA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Chloramphenicol",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kloramfenikol",
"language": "no"
} ]
}, {
"code": "J04AA01",
"display": "Aminosalicylic acid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Aminosalicylic acid and derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AA01",
"display": "J04AA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Aminosalicylic acid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aminosalisylsyre",
"language": "no"
} ]
}, {
"code": "J04AK02",
"display": "Ethambutol",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AK02",
"display": "J04AK02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AK02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ethambutol",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Etambutol",
"language": "no"
} ]
}, {
"code": "J05AJ04",
"display": "Cabotegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Integrase inhibitores"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AJ04",
"display": "J05AJ04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-10-15T00:00:00Z",
"display": "2020-10-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AJ04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cabotegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kabotegravir",
"language": "no"
} ]
}, {
"code": "J05AH",
"display": "Neuraminidase inhibitors",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AH",
"display": "J05AH"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AH"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Neuraminidase inhibitors",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Neuraminidasehemmere",
"language": "no"
} ]
}, {
"code": "J07BX02",
"display": "Ebola vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BX02",
"display": "J07BX02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-11-19T00:00:00Z",
"display": "2019-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BX02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ebola vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ebolavaksiner",
"language": "no"
} ]
}, {
"code": "J01AA03",
"display": "Chlortetracycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA03",
"display": "J01AA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-25T00:00:00Z",
"display": "2013-10-25T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Chlortetracycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Klortetrasyklin",
"language": "no"
} ]
}, {
"code": "J01GB01",
"display": "Tobramycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB01",
"display": "J01GB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tobramycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tobramycin",
"language": "no"
} ]
}, {
"code": "J02AC05",
"display": "Isavuconazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Triazole and tetrazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AC05",
"display": "J02AC05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AC05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Isavuconazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Isavukonazol",
"language": "no"
} ]
}, {
"code": "J06BD03",
"display": "Tixagevimab and cilgavimab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiviral monoclonal antibodies"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD03",
"display": "J06BD03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tixagevimab and cilgavimab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tiksagevimab og cilgavimab",
"language": "no"
} ]
}, {
"code": "J01AA15",
"display": "Omadacycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA15",
"display": "J01AA15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-01-13T00:00:00Z",
"display": "2021-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Omadacycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Omadasyklin",
"language": "no"
} ]
}, {
"code": "J01XB01",
"display": "Colistin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Polymyxins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XB01",
"display": "J01XB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-14T00:00:00Z",
"display": "2014-10-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Colistin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kolistin",
"language": "no"
} ]
}, {
"code": "J01MA23",
"display": "Delafloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA23",
"display": "J01MA23"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-12-20T00:00:00Z",
"display": "2018-12-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA23"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Delafloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Delafloksacin",
"language": "no"
} ]
}, {
"code": "J04AM",
"display": "Combinations of drugs for treatment of tuberculosis",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM",
"display": "J04AM"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations of drugs for treatment of tuberculosis",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Midler til behandling av tuberkulose, kombinasjoner",
"language": "no"
} ]
}, {
"code": "J04AM03",
"display": "Ethambutol and isoniazid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM03",
"display": "J04AM03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ethambutol and isoniazid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Etambutol og isoniazid",
"language": "no"
} ]
}, {
"code": "J01MA05",
"display": "Temafloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA05",
"display": "J01MA05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-14T00:00:00Z",
"display": "2011-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Temafloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Temafloksacin",
"language": "no"
} ]
}, {
"code": "J01EB03",
"display": "Sulfadimidine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Short-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB03",
"display": "J01EB03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfadimidine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfadimidin",
"language": "no"
} ]
}, {
"code": "J05AR02",
"display": "Lamivudine and abacavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR02",
"display": "J05AR02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lamivudine and abacavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lamivudin og abakavir",
"language": "no"
} ]
}, {
"code": "J07BF01",
"display": "Poliomyelitis oral, monovalent live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Poliomyelitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BF01",
"display": "J07BF01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BF01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Poliomyelitis oral, monovalent live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Poliomyelitt oral, monovalent, levende, svekket",
"language": "no"
} ]
}, {
"code": "J01CF04",
"display": "Oxacillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase resistant penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CF04",
"display": "J01CF04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CF04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Oxacillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Oksacillin",
"language": "no"
} ]
}, {
"code": "J07BA03",
"display": "Encephalitis, Japanese, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Encephalitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BA03",
"display": "J07BA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Encephalitis, Japanese, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Japansk encefalitt, levende, svekket",
"language": "no"
} ]
}, {
"code": "J06BB02",
"display": "Tetanus immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB02",
"display": "J06BB02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetanus immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot stivkrampe",
"language": "no"
} ]
}, {
"code": "J01DB08",
"display": "Cefapirin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB08",
"display": "J01DB08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefapirin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefapirin",
"language": "no"
} ]
}, {
"code": "J02A",
"display": "Antimycotics for systemic use",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02A",
"display": "J02A"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02A"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antimycotics for systemic use",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antimykotika til systemisk bruk",
"language": "no"
} ]
}, {
"code": "J06B",
"display": "Immunoglobulins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immune sera and immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06B",
"display": "J06B"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06B"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Immunoglobulins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobuliner",
"language": "no"
} ]
}, {
"code": "J01MB04",
"display": "Pipemidic acid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other quinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MB04",
"display": "J01MB04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-19T00:00:00Z",
"display": "2014-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MB04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pipemidic acid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pipemidinsyre",
"language": "no"
} ]
}, {
"code": "J01ED04",
"display": "Sulfametoxydiazine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED04",
"display": "J01ED04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfametoxydiazine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfametoksydiazin",
"language": "no"
} ]
}, {
"code": "J01EB05",
"display": "Sulfafurazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Short-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB05",
"display": "J01EB05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfafurazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfafurazol",
"language": "no"
} ]
}, {
"code": "J04AA03",
"display": "Calcium aminosalicylate",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Aminosalicylic acid and derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AA03",
"display": "J04AA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Calcium aminosalicylate",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aminosalylkalsium",
"language": "no"
} ]
}, {
"code": "J05AG04",
"display": "Etravirine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Non-nucleoside reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AG04",
"display": "J05AG04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2008-11-24T00:00:00Z",
"display": "2008-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AG04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Etravirine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Etravirin",
"language": "no"
} ]
}, {
"code": "J01EB06",
"display": "Sulfanilamide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Short-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB06",
"display": "J01EB06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfanilamide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfanilamid",
"language": "no"
} ]
}, {
"code": "J01DB03",
"display": "Cefalotin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB03",
"display": "J01DB03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefalotin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefalotin",
"language": "no"
} ]
}, {
"code": "J05AH04",
"display": "Laninamivir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Neuraminidase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AH04",
"display": "J05AH04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AH04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Laninamivir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Laninamivir",
"language": "no"
} ]
}, {
"code": "J05AF04",
"display": "Stavudine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF04",
"display": "J05AF04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Stavudine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Stavudin",
"language": "no"
} ]
}, {
"code": "J01DC13",
"display": "Cefbuperazone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC13",
"display": "J01DC13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-14T00:00:00Z",
"display": "2011-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefbuperazone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefbuperazon",
"language": "no"
} ]
}, {
"code": "J01MA22",
"display": "Tosufloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA22",
"display": "J01MA22"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-12-20T00:00:00Z",
"display": "2018-12-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA22"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tosufloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tosufloksacin",
"language": "no"
} ]
}, {
"code": "J01DD11",
"display": "Cefpiramide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD11",
"display": "J01DD11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefpiramide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefpiramid",
"language": "no"
} ]
}, {
"code": "J01DD58",
"display": "Cefixime and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD58",
"display": "J01DD58"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2023-11-15T00:00:00Z",
"display": "2023-11-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD58"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefixime and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefiksim og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J05AE01",
"display": "Saquinavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE01",
"display": "J05AE01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Saquinavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sakinavir",
"language": "no"
} ]
}, {
"code": "J07BK01",
"display": "Varicella, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Varicella zoster vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BK01",
"display": "J07BK01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BK01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Varicella, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Varicella, levende, svekket",
"language": "no"
} ]
}, {
"code": "J07AX",
"display": "Other bacterial vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AX",
"display": "J07AX"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AX"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other bacterial vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre bakterievaksiner",
"language": "no"
} ]
}, {
"code": "J07XA",
"display": "Parasitic vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07X",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07XA",
"display": "J07XA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-06T00:00:00Z",
"display": "2022-05-06T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07XA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Parasitic vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Parasittvaksiner",
"language": "no"
} ]
}, {
"code": "J01XA03",
"display": "Telavancin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Glycopeptide antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XA03",
"display": "J01XA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Telavancin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Telavancin",
"language": "no"
} ]
}, {
"code": "J07BP02",
"display": "Chikungunya, virus-like particles",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Chikungunya vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BP02",
"display": "J07BP02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2025-06-02T00:00:00Z",
"display": "2025-06-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BP02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Chikungunya, virus-like particles",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Chikungunya, virus-lignende partikler",
"language": "no"
} ]
}, {
"code": "J01XX10",
"display": "Bacitracin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX10",
"display": "J01XX10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-13T00:00:00Z",
"display": "2010-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bacitracin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bacitracin",
"language": "no"
} ]
}, {
"code": "J07BD51",
"display": "Measles, combinations with mumps, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Measles vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BD51",
"display": "J07BD51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BD51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Measles, combinations with mumps, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meslinger, kombinasjoner med kusma, levende svekket",
"language": "no"
} ]
}, {
"code": "J01MA12",
"display": "Levofloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA12",
"display": "J01MA12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Levofloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Levofloksacin",
"language": "no"
} ]
}, {
"code": "J01RA01",
"display": "Penicillins, combinations with other antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA01",
"display": "J01RA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-08-26T00:00:00Z",
"display": "2020-08-26T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Penicillins, combinations with other antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Penicilliner, kombinasjoner med andre antibakterielle midler",
"language": "no"
} ]
}, {
"code": "J05AR18",
"display": "Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR18",
"display": "J05AR18"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR18"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin, tenofoviralafenamid, elvitegravir og kobicistat",
"language": "no"
} ]
}, {
"code": "J01CA02",
"display": "Pivampicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA02",
"display": "J01CA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pivampicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pivampicillin",
"language": "no"
} ]
}, {
"code": "J01DE51",
"display": "Cefepime and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fourth-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DE51",
"display": "J01DE51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DE51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefepime and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefepim og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J04AK04",
"display": "Morinamide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AK04",
"display": "J04AK04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AK04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Morinamide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Morinamid",
"language": "no"
} ]
}, {
"code": "J07BB04",
"display": "Influenza, virus like particles",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Influenza vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BB04",
"display": "J07BB04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-11-11T00:00:00Z",
"display": "2020-11-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BB04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Influenza, virus like particles",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Influensa, viruslignende partikler",
"language": "no"
} ]
}, {
"code": "J01CF02",
"display": "Cloxacillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase resistant penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CF02",
"display": "J01CF02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CF02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cloxacillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kloksacillin",
"language": "no"
} ]
}, {
"code": "J01DH51",
"display": "Imipenem and cilastatin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Carbapenems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH51",
"display": "J01DH51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-02T00:00:00Z",
"display": "2018-01-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Imipenem and cilastatin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Imipenem og cilastatin",
"language": "no"
} ]
}, {
"code": "J05AR19",
"display": "Emtricitabine, tenofovir alafenamide and rilpivirine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR19",
"display": "J05AR19"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR19"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine, tenofovir alafenamide and rilpivirine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin, tenofoviralafenamid og rilpivirin",
"language": "no"
} ]
}, {
"code": "J04AB03",
"display": "Rifamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibiotics"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AB03",
"display": "J04AB03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AB03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifamycin",
"language": "no"
} ]
}, {
"code": "J07AM",
"display": "Tetanus vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AM",
"display": "J07AM"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AM"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetanus vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetanusvaksiner",
"language": "no"
} ]
}, {
"code": "J05AP52",
"display": "Dasabuvir, ombitasvir, paritaprevir and ritonavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX66",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Dasabuvir, ombitasvir, paritaprevir and ritonavir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP52",
"display": "J05AP52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dasabuvir, ombitasvir, paritaprevir and ritonavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dasabuvir, ombitasvir, paritaprevir og ritonavir",
"language": "no"
} ]
}, {
"code": "J01B",
"display": "Amphenicols",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01B",
"display": "J01B"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-07-04T00:00:00Z",
"display": "2014-07-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01B"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Amphenicols",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Amfenikoler",
"language": "no"
} ]
}, {
"code": "J05AF09",
"display": "Emtricitabine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF09",
"display": "J05AF09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2003-11-27T00:00:00Z",
"display": "2003-11-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin",
"language": "no"
} ]
}, {
"code": "J07CA12",
"display": "Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA12",
"display": "J07CA12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-01-01T00:00:00Z",
"display": "2007-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-kikhoste-poliomyelitt-tetanus-hepatitt B",
"language": "no"
} ]
}, {
"code": "J06BB01",
"display": "Anti-D (rh) immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB01",
"display": "J06BB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Anti-D (rh) immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot rh-immunisering",
"language": "no"
} ]
}, {
"code": "J01DB10",
"display": "Cefacetrile",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB10",
"display": "J01DB10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefacetrile",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefacetril",
"language": "no"
} ]
}, {
"code": "J05AX12",
"display": "Dolutegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX12",
"display": "J05AX12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2021-03-02T00:00:00Z",
"display": "2021-03-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dolutegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dolutegravir",
"language": "no"
} ]
}, {
"code": "J01DI04",
"display": "Cefiderocol",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DI",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other cephalosporins and penems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DI04",
"display": "J01DI04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-10-12T00:00:00Z",
"display": "2020-10-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DI04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefiderocol",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefiderokol",
"language": "no"
} ]
}, {
"code": "J01DI03",
"display": "Faropenem",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DI",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other cephalosporins and penems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DI03",
"display": "J01DI03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DI03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Faropenem",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Faropenem",
"language": "no"
} ]
}, {
"code": "J01CR",
"display": "Combinations of penicillins, incl. beta-lactamase inhibitors",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01C",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactam antibacterials, penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CR",
"display": "J01CR"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-28T00:00:00Z",
"display": "2015-01-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CR"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations of penicillins, incl. beta-lactamase inhibitors",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner av penicilliner, inkludert beta-laktamasehemmere",
"language": "no"
} ]
}, {
"code": "J07AH06",
"display": "Meningococcus B, outer membrane vesicle vaccine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH06",
"display": "J07AH06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcus B, outer membrane vesicle vaccine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokk B, yttermembran vesikkel vaksine",
"language": "no"
} ]
}, {
"code": "J05AP54",
"display": "Elbasvir and grazoprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX68",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Elbasvir and grazoprevir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP54",
"display": "J05AP54"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP54"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Elbasvir and grazoprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Elbasvir og grazoprevir",
"language": "no"
} ]
}, {
"code": "J05AE08",
"display": "Atazanavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE08",
"display": "J05AE08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2006-05-30T00:00:00Z",
"display": "2006-05-30T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Atazanavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Atazanavir",
"language": "no"
} ]
}, {
"code": "J01CE",
"display": "Beta-lactamase sensitive penicillins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01C",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactam antibacterials, penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE",
"display": "J01CE"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-02T00:00:00Z",
"display": "2014-10-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Beta-lactamase sensitive penicillins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Beta-laktamaseømfintlige penicilliner",
"language": "no"
} ]
}, {
"code": "J07B",
"display": "Viral vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07B",
"display": "J07B"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07B"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Viral vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Virusvaksiner",
"language": "no"
} ]
}, {
"code": "J01XX12",
"display": "Lefamulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX12",
"display": "J01XX12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-12-15T00:00:00Z",
"display": "2019-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lefamulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lefamulin",
"language": "no"
} ]
}, {
"code": "J06BB14",
"display": "Measles immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB14",
"display": "J06BB14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Measles immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot meslinger",
"language": "no"
} ]
}, {
"code": "J05AX14",
"display": "Daclatasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX14",
"display": "J05AX14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-05-13T00:00:00Z",
"display": "2014-05-13T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Daclatasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Daklatasvir",
"language": "no"
} ]
}, {
"code": "J05AX18",
"display": "Letermovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX18",
"display": "J05AX18"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-11-17T00:00:00Z",
"display": "2017-11-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX18"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Letermovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Letermovir",
"language": "no"
} ]
}, {
"code": "J01RA04",
"display": "Spiramycin and metronidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA04",
"display": "J01RA04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Spiramycin and metronidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Spiramycin og metronidazol",
"language": "no"
} ]
}, {
"code": "J01DC04",
"display": "Cefaclor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC04",
"display": "J01DC04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-08T00:00:00Z",
"display": "2014-10-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefaclor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefaklor",
"language": "no"
} ]
}, {
"code": "J04AM01",
"display": "Streptomycin and isoniazid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM01",
"display": "J04AM01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Streptomycin and isoniazid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Streptomycin og isoniazid",
"language": "no"
} ]
}, {
"code": "J01FA",
"display": "Macrolides",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01F",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides, lincosamides and streptogramins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA",
"display": "J01FA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-28T00:00:00Z",
"display": "2014-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Macrolides",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Makrolider",
"language": "no"
} ]
}, {
"code": "J01MA25",
"display": "Lascufloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA25",
"display": "J01MA25"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-12-15T00:00:00Z",
"display": "2020-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA25"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lascufloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Laskufloksacin",
"language": "no"
} ]
}, {
"code": "J01DB",
"display": "First-generation cephalosporins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01D",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other beta-lactam antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB",
"display": "J01DB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-21T00:00:00Z",
"display": "2014-10-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "First-generation cephalosporins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Første generasjon cefalosporiner",
"language": "no"
} ]
}, {
"code": "J05AF02",
"display": "Didanosine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF02",
"display": "J05AF02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Didanosine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Didanosin",
"language": "no"
} ]
}, {
"code": "J02AB01",
"display": "Miconazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Imidazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AB01",
"display": "J02AB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Miconazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Mikonazol",
"language": "no"
} ]
}, {
"code": "J01CA06",
"display": "Bacampicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA06",
"display": "J01CA06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bacampicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bakampicillin",
"language": "no"
} ]
}, {
"code": "J05AX68",
"display": "Elbasvir and grazoprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX68",
"display": "J05AX68"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2016-02-09T00:00:00Z",
"display": "2016-02-09T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX68"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Elbasvir and grazoprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Elbasvir og grazoprevir",
"language": "no"
} ]
}, {
"code": "J05AE04",
"display": "Nelfinavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE04",
"display": "J05AE04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nelfinavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nelfinavir",
"language": "no"
} ]
}, {
"code": "J02AX07",
"display": "Ibrexafungerp",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AX07",
"display": "J02AX07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AX07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ibrexafungerp",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ibreksafungerp",
"language": "no"
} ]
}, {
"code": "J05AB11",
"display": "Valaciclovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB11",
"display": "J05AB11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Valaciclovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Valaciklovir",
"language": "no"
} ]
}, {
"code": "J05AP57",
"display": "Glecaprevir and pibrentasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP57",
"display": "J05AP57"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-23T00:00:00Z",
"display": "2018-01-23T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP57"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Glecaprevir and pibrentasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Glekaprevir og pibrentasvir",
"language": "no"
} ]
}, {
"code": "J01CA09",
"display": "Azlocillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA09",
"display": "J01CA09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Azlocillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Azlocillin",
"language": "no"
} ]
}, {
"code": "J01MB08",
"display": "Nemonoxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other quinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MB08",
"display": "J01MB08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MB08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nemonoxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nemonoksacin",
"language": "no"
} ]
}, {
"code": "J05AF03",
"display": "Zalcitabine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF03",
"display": "J05AF03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Zalcitabine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Zalcitabin",
"language": "no"
} ]
}, {
"code": "J05AR28",
"display": "Stavudine and lamivudine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR28",
"display": "J05AR28"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2023-11-15T00:00:00Z",
"display": "2023-11-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR28"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Stavudine and lamivudine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Stavudin og lamivudin",
"language": "no"
} ]
}, {
"code": "J01DH05",
"display": "Biapenem",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Carbapenems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH05",
"display": "J01DH05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-13T00:00:00Z",
"display": "2010-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Biapenem",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Biapenem",
"language": "no"
} ]
}, {
"code": "J01FA07",
"display": "Josamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA07",
"display": "J01FA07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Josamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Josamycin",
"language": "no"
} ]
}, {
"code": "J04AK07",
"display": "Thioacetazone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AK07",
"display": "J04AK07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AK07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Thioacetazone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tioacetazon",
"language": "no"
} ]
}, {
"code": "J01EB01",
"display": "Sulfaisodimidine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Short-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB01",
"display": "J01EB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfaisodimidine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfaisodimidin",
"language": "no"
} ]
}, {
"code": "J07BB02",
"display": "Influenza, inactivated, split virus or surface antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Influenza vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BB02",
"display": "J07BB02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BB02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Influenza, inactivated, split virus or surface antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Influensa, inaktivert, splitvirus eller overflateantigen",
"language": "no"
} ]
}, {
"code": "J04AM08",
"display": "Isoniazid, sulfamethoxazole and trimethoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM08",
"display": "J04AM08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Isoniazid, sulfamethoxazole and trimethoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Isoniazid, sulfametoksazol og trimetoprim",
"language": "no"
} ]
}, {
"code": "J01DB02",
"display": "Cefaloridine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB02",
"display": "J01DB02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefaloridine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefaloridin",
"language": "no"
} ]
}, {
"code": "J07CA13",
"display": "Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA13",
"display": "J07CA13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-haemophilus influenzae B-kikhoste-tetanus-hepatitt B-meningokokk A+C",
"language": "no"
} ]
}, {
"code": "J06BB15",
"display": "Mumps immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB15",
"display": "J06BB15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Mumps immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot kusma",
"language": "no"
} ]
}, {
"code": "J05AG06",
"display": "Doravirine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Non-nucleoside reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AG06",
"display": "J05AG06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AG06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Doravirine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Doravirin",
"language": "no"
} ]
}, {
"code": "J07BX",
"display": "Other viral vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BX",
"display": "J07BX"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BX"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other viral vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre virusvaksiner",
"language": "no"
} ]
}, {
"code": "J02AC03",
"display": "Voriconazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Triazole and tetrazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AC03",
"display": "J02AC03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2003-02-03T00:00:00Z",
"display": "2003-02-03T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AC03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Voriconazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Vorikonazol",
"language": "no"
} ]
}, {
"code": "J01XD01",
"display": "Metronidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Imidazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XD01",
"display": "J01XD01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XD01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Metronidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Metronidazol",
"language": "no"
} ]
}, {
"code": "J01EA01",
"display": "Trimethoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Trimethoprim and derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EA01",
"display": "J01EA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Trimethoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Trimetoprim",
"language": "no"
} ]
}, {
"code": "J05AF06",
"display": "Abacavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF06",
"display": "J05AF06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Abacavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Abakavir",
"language": "no"
} ]
}, {
"code": "J04AB06",
"display": "Enviomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibiotics"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AB06",
"display": "J04AB06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AB06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Enviomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Enviomycin",
"language": "no"
} ]
}, {
"code": "J01AA04",
"display": "Lymecycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA04",
"display": "J01AA04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-25T00:00:00Z",
"display": "2013-10-25T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lymecycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lymesyklin",
"language": "no"
} ]
}, {
"code": "J05AF10",
"display": "Entecavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF10",
"display": "J05AF10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2006-08-01T00:00:00Z",
"display": "2006-08-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Entecavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Entekavir",
"language": "no"
} ]
}, {
"code": "J05AE15",
"display": "Asunaprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE15",
"display": "J05AE15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-07-15T00:00:00Z",
"display": "2014-07-15T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Asunaprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Asunaprevir",
"language": "no"
} ]
}, {
"code": "J06AA04",
"display": "Botulinum antitoxin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immune sera"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06AA04",
"display": "J06AA04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06AA04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Botulinum antitoxin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Botulinumantitoksin",
"language": "no"
} ]
}, {
"code": "J05AC02",
"display": "Rimantadine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Cyclic amines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AC02",
"display": "J05AC02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AC02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rimantadine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rimantadin",
"language": "no"
} ]
}, {
"code": "J05AR25",
"display": "Lamivudine and dolutegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR25",
"display": "J05AR25"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR25"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lamivudine and dolutegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lamivudin og dolutegravir",
"language": "no"
} ]
}, {
"code": "J01EE05",
"display": "Sulfadimidine and trimethoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of sulfonamides and trimethoprim, incl. derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EE05",
"display": "J01EE05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-21T00:00:00Z",
"display": "2014-11-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EE05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfadimidine and trimethoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfadimidin og trimetoprim",
"language": "no"
} ]
}, {
"code": "J05AR23",
"display": "Atazanavir and ritonavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR23",
"display": "J05AR23"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR23"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Atazanavir and ritonavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Atazanavir og ritonavir",
"language": "no"
} ]
}, {
"code": "J01CF03",
"display": "Meticillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase resistant penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CF03",
"display": "J01CF03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CF03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meticillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meticillin",
"language": "no"
} ]
}, {
"code": "J01RA07",
"display": "Azithromycin, fluconazole and secnidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA07",
"display": "J01RA07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Azithromycin, fluconazole and secnidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Azitromycin, flukonazol og seknidazol",
"language": "no"
} ]
}, {
"code": "J07BA02",
"display": "Encephalitis, Japanese, inactivated, whole virus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Encephalitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BA02",
"display": "J07BA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Encephalitis, Japanese, inactivated, whole virus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Japansk encefalitt, inaktivert helvirus",
"language": "no"
} ]
}, {
"code": "J01DD16",
"display": "Cefditoren",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD16",
"display": "J01DD16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefditoren",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefditoren",
"language": "no"
} ]
}, {
"code": "J07AJ01",
"display": "Pertussis, inactivated, whole cell",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Pertussis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AJ01",
"display": "J07AJ01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AJ01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pertussis, inactivated, whole cell",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kikhoste, inaktivert, helcelle",
"language": "no"
} ]
}, {
"code": "J04AK06",
"display": "Delamanid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AK06",
"display": "J04AK06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AK06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Delamanid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Delamanid",
"language": "no"
} ]
}, {
"code": "J01MB",
"display": "Other quinolones",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01M",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Quinolone antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MB",
"display": "J01MB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-12T00:00:00Z",
"display": "2014-11-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other quinolones",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre kinoloner",
"language": "no"
} ]
}, {
"code": "J01CA11",
"display": "Mecillinam",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA11",
"display": "J01CA11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Mecillinam",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Mecillinam",
"language": "no"
} ]
}, {
"code": "J06BB17",
"display": "Motavizumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB17",
"display": "J06BB17"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2022-01-31T00:00:00Z",
"display": "2022-01-31T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB17"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Motavizumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Motavizumab",
"language": "no"
} ]
}, {
"code": "J04AB02",
"display": "Rifampicin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibiotics"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AB02",
"display": "J04AB02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AB02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifampicin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifampicin",
"language": "no"
} ]
}, {
"code": "J01MA08",
"display": "Fleroxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA08",
"display": "J01MA08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Fleroxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fleroksacin",
"language": "no"
} ]
}, {
"code": "J01DI01",
"display": "Ceftobiprole medocaril",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DI",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other cephalosporins and penems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DI01",
"display": "J01DI01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DI01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftobiprole medocaril",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftobiprolmedokaril",
"language": "no"
} ]
}, {
"code": "J05AP12",
"display": "Koblopasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP12",
"display": "J05AP12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Koblopasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Koblopasvir",
"language": "no"
} ]
}, {
"code": "J01CA12",
"display": "Piperacillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA12",
"display": "J01CA12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Piperacillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Piperacillin",
"language": "no"
} ]
}, {
"code": "J07AK",
"display": "Plague vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AK",
"display": "J07AK"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AK"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Plague vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pestvaksiner",
"language": "no"
} ]
}, {
"code": "J01DD17",
"display": "Cefcapene",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD17",
"display": "J01DD17"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-13T00:00:00Z",
"display": "2010-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD17"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefcapene",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefkapen",
"language": "no"
} ]
}, {
"code": "J01GB14",
"display": "Plazomicin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB14",
"display": "J01GB14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Plazomicin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Plazomicin",
"language": "no"
} ]
}, {
"code": "J01BA02",
"display": "Thiamphenicol",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Amphenicols"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01BA02",
"display": "J01BA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01BA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Thiamphenicol",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tiamfenikol",
"language": "no"
} ]
}, {
"code": "J01GA02",
"display": "Streptoduocin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Streptomycins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GA02",
"display": "J01GA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Streptoduocin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Streptoduocin",
"language": "no"
} ]
}, {
"code": "J07BB01",
"display": "Influenza, inactivated, whole virus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Influenza vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BB01",
"display": "J07BB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Influenza, inactivated, whole virus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Influensa, inaktivert, helvirus",
"language": "no"
} ]
}, {
"code": "J07BM02",
"display": "Papillomavirus (human types 16, 18)",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Papillomavirus vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BM02",
"display": "J07BM02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BM02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Papillomavirus (human types 16, 18)",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Papillomavirus (human type 16,18)",
"language": "no"
} ]
}, {
"code": "J01ED08",
"display": "Sulfaphenazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED08",
"display": "J01ED08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-21T00:00:00Z",
"display": "2014-11-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfaphenazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfafenazol",
"language": "no"
} ]
}, {
"code": "J06BD",
"display": "Antiviral monoclonal antibodies",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD",
"display": "J06BD"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antiviral monoclonal antibodies",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antivirale monoklonale antistoffer",
"language": "no"
} ]
}, {
"code": "J01DB01",
"display": "Cefalexin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB01",
"display": "J01DB01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefalexin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefaleksin",
"language": "no"
} ]
}, {
"code": "J01AA05",
"display": "Metacycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA05",
"display": "J01AA05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-25T00:00:00Z",
"display": "2013-10-25T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Metacycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Metasyklin",
"language": "no"
} ]
}, {
"code": "J01RA14",
"display": "Norfloxacin and metronidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA14",
"display": "J01RA14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-10-15T00:00:00Z",
"display": "2021-10-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Norfloxacin and metronidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Norfloksacin og metronidazol",
"language": "no"
} ]
}, {
"code": "J07AE",
"display": "Cholera vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AE",
"display": "J07AE"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AE"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cholera vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Koleravaksiner",
"language": "no"
} ]
}, {
"code": "J05AR01",
"display": "Zidovudine and lamivudine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR01",
"display": "J05AR01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-01-01T00:00:00Z",
"display": "2007-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Zidovudine and lamivudine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Zidovudin og lamivudin",
"language": "no"
} ]
}, {
"code": "J04AK03",
"display": "Terizidone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AK03",
"display": "J04AK03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AK03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Terizidone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Terizidon",
"language": "no"
} ]
}, {
"code": "J07BX04",
"display": "Dengue virus vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BX04",
"display": "J07BX04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BX04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dengue virus vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Denguevirusvaksiner",
"language": "no"
} ]
}, {
"code": "J07BL",
"display": "Yellow fever vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BL",
"display": "J07BL"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BL"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Yellow fever vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Gulfebervaksiner",
"language": "no"
} ]
}, {
"code": "J01EE03",
"display": "Sulfametrole and trimethoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of sulfonamides and trimethoprim, incl. derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EE03",
"display": "J01EE03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EE03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfametrole and trimethoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfametrol og trimetoprim",
"language": "no"
} ]
}, {
"code": "J06BB19",
"display": "Anthrax immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB19",
"display": "J06BB19"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB19"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Anthrax immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antraksimmunoglobulin",
"language": "no"
} ]
}, {
"code": "J07AK01",
"display": "Plague, inactivated, whole cell",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Plague vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AK01",
"display": "J07AK01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AK01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Plague, inactivated, whole cell",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pest, inaktivert, helcelle",
"language": "no"
} ]
}, {
"code": "J01ED01",
"display": "Sulfadimethoxine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED01",
"display": "J01ED01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfadimethoxine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfadimetoksin",
"language": "no"
} ]
}, {
"code": "J01CA07",
"display": "Epicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA07",
"display": "J01CA07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Epicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Epicillin",
"language": "no"
} ]
}, {
"code": "J01CA18",
"display": "Hetacillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA18",
"display": "J01CA18"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA18"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Hetacillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Hetacillin",
"language": "no"
} ]
}, {
"code": "J01EB20",
"display": "Combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Short-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB20",
"display": "J01EB20"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB20"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner",
"language": "no"
} ]
}, {
"code": "J07AG54",
"display": "Haemophilus influenza B, combinations with meningococcus C,Y, conjugated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Haemophilus influenzae B vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AG54",
"display": "J07AG54"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-03-04T00:00:00Z",
"display": "2021-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AG54"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenza B, combinations with meningococcus C,Y, conjugated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenza B, kombinasjoner med meningococcus C,Y, konjugert",
"language": "no"
} ]
}, {
"code": "J05AX06",
"display": "Pleconaril",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX06",
"display": "J05AX06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pleconaril",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Plekonaril",
"language": "no"
} ]
}, {
"code": "J07BB",
"display": "Influenza vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BB",
"display": "J07BB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Influenza vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Influensavaksiner",
"language": "no"
} ]
}, {
"code": "J01XX04",
"display": "Spectinomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX04",
"display": "J01XX04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-21T00:00:00Z",
"display": "2014-11-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Spectinomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Spektinomycin",
"language": "no"
} ]
}, {
"code": "J05AP",
"display": "Antivirals for treatment of HCV infections",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP",
"display": "J05AP"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-01-11T00:00:00Z",
"display": "2017-01-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antivirals for treatment of HCV infections",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antivirale midler til behandling av HCV infeksjoner",
"language": "no"
} ]
}, {
"code": "J04BA01",
"display": "Clofazimine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of lepra"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04BA01",
"display": "J04BA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04BA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Clofazimine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Klofazimin",
"language": "no"
} ]
}, {
"code": "J07AP01",
"display": "Typhoid, oral, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Typhoid vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AP01",
"display": "J07AP01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AP01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Typhoid, oral, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tyfoid, oral, levende, svekket",
"language": "no"
} ]
}, {
"code": "J07XA01",
"display": "Malaria vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07XA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Parasitic vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07XA01",
"display": "J07XA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07XA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Malaria vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Malariavaksiner",
"language": "no"
} ]
}, {
"code": "J01CF01",
"display": "Dicloxacillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase resistant penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CF01",
"display": "J01CF01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CF01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dicloxacillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dikloksacillin",
"language": "no"
} ]
}, {
"code": "J05AR05",
"display": "Zidovudine, lamivudine and nevirapine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR05",
"display": "J05AR05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Zidovudine, lamivudine and nevirapine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Zidovudin, lamivudin og nevirapin",
"language": "no"
} ]
}, {
"code": "J01MB02",
"display": "Nalidixic acid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other quinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MB02",
"display": "J01MB02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MB02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nalidixic acid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nalidiksinsyre",
"language": "no"
} ]
}, {
"code": "J07AJ",
"display": "Pertussis vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AJ",
"display": "J07AJ"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AJ"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pertussis vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kikhostevaksiner",
"language": "no"
} ]
}, {
"code": "J05AJ03",
"display": "Dolutegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Integrase inhibitores"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX12",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Dolutegravir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AJ03",
"display": "J05AJ03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-12-14T00:00:00Z",
"display": "2020-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AJ03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dolutegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dolutegravir",
"language": "no"
} ]
}, {
"code": "J05AR20",
"display": "Emtricitabine, tenofovir alafenamide and bictegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR20",
"display": "J05AR20"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-12-01T00:00:00Z",
"display": "2017-12-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR20"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine, tenofovir alafenamide and bictegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin, tenofoviralafenamid og biktegravir",
"language": "no"
} ]
}, {
"code": "J05AX65",
"display": "Sofosbuvir and ledipasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX65",
"display": "J05AX65"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-29T00:00:00Z",
"display": "2014-12-29T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX65"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir and ledipasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir and ledipasvir",
"language": "no"
} ]
}, {
"code": "J07BC02",
"display": "Hepatitis A, inactivated, whole virus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Hepatitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BC02",
"display": "J07BC02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BC02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Hepatitis A, inactivated, whole virus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Hepatitt A, inaktivert, helvirus",
"language": "no"
} ]
}, {
"code": "J04AM11",
"display": "Rifabutin, pyrazinamide and protionamide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM11",
"display": "J04AM11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifabutin, pyrazinamide and protionamide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifabutin, pyrazinamid og protionamid",
"language": "no"
} ]
}, {
"code": "J01GA",
"display": "Streptomycins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01G",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Aminoglycoside antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GA",
"display": "J01GA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Streptomycins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Streptomyciner",
"language": "no"
} ]
}, {
"code": "J07AH11",
"display": "Meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH11",
"display": "J07AH11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-09-27T00:00:00Z",
"display": "2024-09-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokk A,B,C,Y,W-135, pentavalent renset polusakkarid antigenkonjugert og faktor H-bindende protein",
"language": "no"
} ]
}, {
"code": "J01EE04",
"display": "Sulfamoxole and trimethoprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of sulfonamides and trimethoprim, incl. derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EE04",
"display": "J01EE04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-15T00:00:00Z",
"display": "2011-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EE04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfamoxole and trimethoprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfamoksol og trimetoprim",
"language": "no"
} ]
}, {
"code": "J01CA03",
"display": "Carbenicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA03",
"display": "J01CA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-08T00:00:00Z",
"display": "2014-10-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Carbenicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Karbenicillin",
"language": "no"
} ]
}, {
"code": "J04AM05",
"display": "Rifampicin, pyrazinamide and isoniazid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM05",
"display": "J04AM05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2006-03-13T00:00:00Z",
"display": "2006-03-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifampicin, pyrazinamide and isoniazid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifampicin, pyrazinamid og isoniazid",
"language": "no"
} ]
}, {
"code": "J02AA01",
"display": "Amphotericin B",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibiotics"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AA01",
"display": "J02AA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Amphotericin B",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Amfotericin B",
"language": "no"
} ]
}, {
"code": "J01DB11",
"display": "Cefroxadine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB11",
"display": "J01DB11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-06-07T00:00:00Z",
"display": "2010-06-07T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefroxadine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefroksadin",
"language": "no"
} ]
}, {
"code": "J01RA05",
"display": "Levofloxacin and ornidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA05",
"display": "J01RA05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Levofloxacin and ornidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Levofloksacin og ornidazol",
"language": "no"
} ]
}, {
"code": "J05AR",
"display": "Antivirals for treatment of HIV infections, combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR",
"display": "J05AR"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antivirals for treatment of HIV infections, combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antivirale midler til behandling av HIV infeksjoner, kombinasjoner",
"language": "no"
} ]
}, {
"code": "J01FA16",
"display": "Solithromycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA16",
"display": "J01FA16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2016-12-20T00:00:00Z",
"display": "2016-12-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Solithromycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Solitromycin",
"language": "no"
} ]
}, {
"code": "J01DH56",
"display": "Imipenem, cilastatin and relebactam",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Carbapenems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH56",
"display": "J01DH56"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-10-12T00:00:00Z",
"display": "2020-10-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH56"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Imipenem, cilastatin and relebactam",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Imipenem, cilastatin og relebaktam",
"language": "no"
} ]
}, {
"code": "J04AM12",
"display": "Rifampicin, pyrazinamide, isoniazid and levofloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM12",
"display": "J04AM12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifampicin, pyrazinamide, isoniazid and levofloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifampicin, pyrazinamid, isoniazid og levofloksacin",
"language": "no"
} ]
}, {
"code": "J01M",
"display": "Quinolone antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01M",
"display": "J01M"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-01-13T00:00:00Z",
"display": "2021-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01M"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Quinolone antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kinolon, antibakterielle",
"language": "no"
} ]
}, {
"code": "J06BD06",
"display": "Regdanvimab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiviral monoclonal antibodies"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD06",
"display": "J06BD06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-08T00:00:00Z",
"display": "2021-12-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Regdanvimab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Regdanvimab",
"language": "no"
} ]
}, {
"code": "J05AX33",
"display": "Labuvirtide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX33",
"display": "J05AX33"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX33"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Labuvirtide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Labuvirtid",
"language": "no"
} ]
}, {
"code": "J01AA08",
"display": "Minocycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA08",
"display": "J01AA08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Minocycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Minosyklin",
"language": "no"
} ]
}, {
"code": "J07CA",
"display": "Bacterial and viral vaccines, combined",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07C",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA",
"display": "J07CA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bacterial and viral vaccines, combined",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bakterie- og virusvaksiner, kombinert",
"language": "no"
} ]
}, {
"code": "J01MA15",
"display": "Gemifloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA15",
"display": "J01MA15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Gemifloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Gemifloksacin",
"language": "no"
} ]
}, {
"code": "J07AH01",
"display": "Meningococcus A, purified polysaccharides antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH01",
"display": "J07AH01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcus A, purified polysaccharides antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokk A, renset polysakkarid antigen",
"language": "no"
} ]
}, {
"code": "J05AR07",
"display": "Stavudine, lamivudine and nevirapine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR07",
"display": "J05AR07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Stavudine, lamivudine and nevirapine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Stavudin, lamivudin og nevirapin",
"language": "no"
} ]
}, {
"code": "J01DH55",
"display": "Panipenem and betamipron",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Carbapenems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH55",
"display": "J01DH55"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH55"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Panipenem and betamipron",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Panipenem og betamipron",
"language": "no"
} ]
}, {
"code": "J01XA02",
"display": "Teicoplanin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Glycopeptide antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XA02",
"display": "J01XA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Teicoplanin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Teikoplanin",
"language": "no"
} ]
}, {
"code": "J01MB03",
"display": "Piromidic acid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other quinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MB03",
"display": "J01MB03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-20T00:00:00Z",
"display": "2014-11-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MB03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Piromidic acid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Piromidinsyre",
"language": "no"
} ]
}, {
"code": "J01AA20",
"display": "Combinations of tetracyclines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA20",
"display": "J01AA20"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-25T00:00:00Z",
"display": "2013-10-25T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA20"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations of tetracyclines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner av tetrasykliner",
"language": "no"
} ]
}, {
"code": "J05AE06",
"display": "Lopinavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE06",
"display": "J05AE06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2004-08-11T00:00:00Z",
"display": "2004-08-11T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2013-01-03T00:00:00Z",
"display": "2013-01-03T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lopinavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lopinavir",
"language": "no"
} ]
}, {
"code": "J04AM06",
"display": "Rifampicin, pyrazinamide, ethambutol and isoniazid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM06",
"display": "J04AM06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2006-03-13T00:00:00Z",
"display": "2006-03-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifampicin, pyrazinamide, ethambutol and isoniazid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifampicin, pyrazinamid, etambutol og isoniazid",
"language": "no"
} ]
}, {
"code": "J01CA15",
"display": "Talampicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA15",
"display": "J01CA15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Talampicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Talampicillin",
"language": "no"
} ]
}, {
"code": "J02",
"display": "Antimycotics for systemic use",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiinfectives for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02",
"display": "J02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antimycotics for systemic use",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antimykotika til systemisk bruk",
"language": "no"
} ]
}, {
"code": "J04AD03",
"display": "Ethionamide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Thiocarbamide derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AD03",
"display": "J04AD03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AD03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ethionamide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Etionamid",
"language": "no"
} ]
}, {
"code": "J05AG02",
"display": "Delavirdine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Non-nucleoside reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AG02",
"display": "J05AG02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AG02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Delavirdine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Delavirdin",
"language": "no"
} ]
}, {
"code": "J05AR11",
"display": "Lamivudine, tenofovir disoproxil and efavirenz",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR11",
"display": "J05AR11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lamivudine, tenofovir disoproxil and efavirenz",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lamivudin, tenofovirdisoproksil og efavirenz",
"language": "no"
} ]
}, {
"code": "J01FA12",
"display": "Rokitamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA12",
"display": "J01FA12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rokitamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rokitamycin",
"language": "no"
} ]
}, {
"code": "J01CR04",
"display": "Sultamicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of penicillins, incl. beta-lactamase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CR04",
"display": "J01CR04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CR04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sultamicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sultamicillin",
"language": "no"
} ]
}, {
"code": "J01DD12",
"display": "Cefoperazone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD12",
"display": "J01DD12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefoperazone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefoperazon",
"language": "no"
} ]
}, {
"code": "J01DH",
"display": "Carbapenems",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01D",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other beta-lactam antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH",
"display": "J01DH"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-08T00:00:00Z",
"display": "2014-10-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Carbapenems",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Karbapenemer",
"language": "no"
} ]
}, {
"code": "J01EA03",
"display": "Iclaprim",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Trimethoprim and derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EA03",
"display": "J01EA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-13T00:00:00Z",
"display": "2010-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Iclaprim",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Iklaprim",
"language": "no"
} ]
}, {
"code": "J01AA14",
"display": "Sarecycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA14",
"display": "J01AA14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-01-13T00:00:00Z",
"display": "2021-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sarecycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Saresyklin",
"language": "no"
} ]
}, {
"code": "J05AE03",
"display": "Ritonavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE03",
"display": "J05AE03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ritonavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ritonavir",
"language": "no"
} ]
}, {
"code": "J01ED",
"display": "Long-acting sulfonamides",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01E",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Sulfonamides and trimethoprim"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED",
"display": "J01ED"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Long-acting sulfonamides",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfonamider med lang virketid",
"language": "no"
} ]
}, {
"code": "J07CA05",
"display": "Diphtheria-hepatitis B-pertussis-tetanus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA05",
"display": "J07CA05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-hepatitis B-pertussis-tetanus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-hepatitt B-kikhoste-tetanus",
"language": "no"
} ]
}, {
"code": "J05AF07",
"display": "Tenofovir disoproxil",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF07",
"display": "J05AF07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2004-02-24T00:00:00Z",
"display": "2004-02-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tenofovir disoproxil",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tenofovirdisoproksil",
"language": "no"
} ]
}, {
"code": "J01FA15",
"display": "Telithromycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA15",
"display": "J01FA15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Telithromycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Telitromycin",
"language": "no"
} ]
}, {
"code": "J06",
"display": "Immune sera and immunoglobulins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiinfectives for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06",
"display": "J06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Immune sera and immunoglobulins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunsera og immunoglobuliner",
"language": "no"
} ]
}, {
"code": "J07X",
"display": "Other vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07X",
"display": "J07X"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07X"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre vaksiner",
"language": "no"
} ]
}, {
"code": "J01XB",
"display": "Polymyxins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01X",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XB",
"display": "J01XB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Polymyxins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Polymyksiner",
"language": "no"
} ]
}, {
"code": "J05AB02",
"display": "Idoxuridine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB02",
"display": "J05AB02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Idoxuridine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Idoksuridin",
"language": "no"
} ]
}, {
"code": "J04AB30",
"display": "Capreomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibiotics"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AB30",
"display": "J04AB30"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AB30"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Capreomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kapreomycin",
"language": "no"
} ]
}, {
"code": "J01EC20",
"display": "Combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Intermediate-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EC20",
"display": "J01EC20"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EC20"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner",
"language": "no"
} ]
}, {
"code": "J02AA",
"display": "Antibiotics",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AA",
"display": "J02AA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antibiotics",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antibiotika",
"language": "no"
} ]
}, {
"code": "J07BK02",
"display": "Zoster, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Varicella zoster vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BK02",
"display": "J07BK02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BK02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Zoster, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Zoster, levende svekket",
"language": "no"
} ]
}, {
"code": "J05AG05",
"display": "Rilpivirine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Non-nucleoside reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AG05",
"display": "J05AG05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AG05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rilpivirine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rilpivirin",
"language": "no"
} ]
}, {
"code": "J01EE",
"display": "Combinations of sulfonamides and trimethoprim, incl. derivatives",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01E",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Sulfonamides and trimethoprim"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EE",
"display": "J01EE"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EE"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations of sulfonamides and trimethoprim, incl. derivatives",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner av sulfonamider og trimetoprim, inkl. derivater",
"language": "no"
} ]
}, {
"code": "J06BB07",
"display": "Vaccinia immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB07",
"display": "J06BB07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Vaccinia immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot kukopper",
"language": "no"
} ]
}, {
"code": "J01RA03",
"display": "Cefuroxime and metronodazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA03",
"display": "J01RA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-08-26T00:00:00Z",
"display": "2020-08-26T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefuroxime and metronodazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefuroksim og metronidazol",
"language": "no"
} ]
}, {
"code": "J01ED02",
"display": "Sulfalene",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED02",
"display": "J01ED02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfalene",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfalen",
"language": "no"
} ]
}, {
"code": "J01EB",
"display": "Short-acting sulfonamides",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01E",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Sulfonamides and trimethoprim"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EB",
"display": "J01EB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Short-acting sulfonamides",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfonamider med kort virketid",
"language": "no"
} ]
}, {
"code": "J07AH03",
"display": "Meningococcus A,C, bivalent purified polysaccharides antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH03",
"display": "J07AH03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcus A,C, bivalent purified polysaccharides antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokk A,C, divalent renset polysakkarid antigen",
"language": "no"
} ]
}, {
"code": "J01MA17",
"display": "Prulifloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA17",
"display": "J01MA17"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA17"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Prulifloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Prulifloksacin",
"language": "no"
} ]
}, {
"code": "J07AL52",
"display": "Pneumococcus purified polysaccharides antigen and haemophilius influenzae, conjugated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AL",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Pneumococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AL52",
"display": "J07AL52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2009-03-20T00:00:00Z",
"display": "2009-03-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AL52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pneumococcus purified polysaccharides antigen and haemophilius influenzae, conjugated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pneumokokk, renset polysakkarid antigen og haemophilus influenzae, konjugert",
"language": "no"
} ]
}, {
"code": "J05AF13",
"display": "Tenofovir alafenamide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF13",
"display": "J05AF13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2016-12-20T00:00:00Z",
"display": "2016-12-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tenofovir alafenamide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tenofoviralafenamid",
"language": "no"
} ]
}, {
"code": "J05AP06",
"display": "Asunaprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AE15",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Asunaprevir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP06",
"display": "J05AP06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Asunaprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Asunaprevir",
"language": "no"
} ]
}, {
"code": "J05AX08",
"display": "Raltegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX08",
"display": "J05AX08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2021-03-02T00:00:00Z",
"display": "2021-03-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Raltegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Raltegravir",
"language": "no"
} ]
}, {
"code": "J01CA51",
"display": "Ampicillin, combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA51",
"display": "J01CA51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ampicillin, combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ampicillin, kombinasjoner",
"language": "no"
} ]
}, {
"code": "J01BA",
"display": "Amphenicols",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Amphenicols"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01BA",
"display": "J01BA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01BA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Amphenicols",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Amfenikoler",
"language": "no"
} ]
}, {
"code": "J06BB",
"display": "Specific immunoglobulins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB",
"display": "J06BB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Specific immunoglobulins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Spesifikke immunglobuliner",
"language": "no"
} ]
}, {
"code": "J01RA10",
"display": "Ciprofloxacin and metronidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA10",
"display": "J01RA10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ciprofloxacin and metronidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ciprofloksacin og metronidazol",
"language": "no"
} ]
}, {
"code": "J01MB06",
"display": "Cinoxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other quinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MB06",
"display": "J01MB06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MB06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cinoxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cinoksacin",
"language": "no"
} ]
}, {
"code": "J01DD10",
"display": "Cefetamet",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD10",
"display": "J01DD10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefetamet",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefetamet",
"language": "no"
} ]
}, {
"code": "J01XX01",
"display": "Fosfomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX01",
"display": "J01XX01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Fosfomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fosfomycin",
"language": "no"
} ]
}, {
"code": "J01FG02",
"display": "Quinupristin/dalfopristin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Streptogramins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FG02",
"display": "J01FG02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FG02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Quinupristin/dalfopristin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kinupristin/dalfopristin",
"language": "no"
} ]
}, {
"code": "J05AP55",
"display": "Sofosbuvir and velpatasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX69",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Sofosbuvir and velpatasvir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP55",
"display": "J05AP55"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP55"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir and velpatasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir og velpatasvir",
"language": "no"
} ]
}, {
"code": "J04AC01",
"display": "Isoniazid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Hydrazides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AC01",
"display": "J04AC01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AC01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Isoniazid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Isoniazid",
"language": "no"
} ]
}, {
"code": "J04BA50",
"display": "Dapsone and rifampicin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of lepra"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04BA50",
"display": "J04BA50"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04BA50"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dapsone and rifampicin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dapson og rifampicin",
"language": "no"
} ]
}, {
"code": "J01DI",
"display": "Other cephalosporins and penems",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01D",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other beta-lactam antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DI",
"display": "J01DI"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DI"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other cephalosporins and penems",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre cefalosporiner og penemer",
"language": "no"
} ]
}, {
"code": "J05AP53",
"display": "Ombitasvir, paritaprevir and ritonavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX67",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Ombitasvir, paritaprevir and ritonavir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP53",
"display": "J05AP53"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP53"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ombitasvir, paritaprevir and ritonavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ombitasvir, paritaprevir og ritonavir",
"language": "no"
} ]
}, {
"code": "J01DH52",
"display": "Meropenem and vaborbactam",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Carbapenems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH52",
"display": "J01DH52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-12-20T00:00:00Z",
"display": "2018-12-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meropenem and vaborbactam",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meropenem og vaborbaktam",
"language": "no"
} ]
}, {
"code": "J04AK08",
"display": "Pretomanid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AK08",
"display": "J04AK08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-08-20T00:00:00Z",
"display": "2020-08-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AK08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pretomanid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pretomanid",
"language": "no"
} ]
}, {
"code": "J02AC02",
"display": "Itraconazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Triazole and tetrazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AC02",
"display": "J02AC02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AC02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Itraconazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Itrakonazol",
"language": "no"
} ]
}, {
"code": "J05AP07",
"display": "Daclatasvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX14",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Daclatasvir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP07",
"display": "J05AP07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Daclatasvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Daklatasvir",
"language": "no"
} ]
}, {
"code": "J01XX08",
"display": "Linezolid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX08",
"display": "J01XX08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Linezolid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Linezolid",
"language": "no"
} ]
}, {
"code": "J01CE06",
"display": "Penamecillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE06",
"display": "J01CE06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Penamecillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Penamecillin",
"language": "no"
} ]
}, {
"code": "J01GB",
"display": "Other aminoglycosides",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01G",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Aminoglycoside antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB",
"display": "J01GB"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-12T00:00:00Z",
"display": "2014-11-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other aminoglycosides",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre aminoglykosider",
"language": "no"
} ]
}, {
"code": "J01DB06",
"display": "Cefazedone",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB06",
"display": "J01DB06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefazedone",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefazedon",
"language": "no"
} ]
}, {
"code": "J05AE09",
"display": "Tipranavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Protease inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AE09",
"display": "J05AE09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2006-02-01T00:00:00Z",
"display": "2006-02-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AE09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tipranavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tipranavir",
"language": "no"
} ]
}, {
"code": "J01MA03",
"display": "Pefloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA03",
"display": "J01MA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pefloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pefloksacin",
"language": "no"
} ]
}, {
"code": "J05AX25",
"display": "Baloxavir marboxil",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX25",
"display": "J05AX25"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX25"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Baloxavir marboxil",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Baloksavirmarboksil",
"language": "no"
} ]
}, {
"code": "J01DD64",
"display": "Cefpodoxime and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD64",
"display": "J01DD64"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-12-20T00:00:00Z",
"display": "2018-12-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD64"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefpodoxime and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefpodoksim og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J01XX07",
"display": "Nitroxoline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX07",
"display": "J01XX07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nitroxoline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nitroksolin",
"language": "no"
} ]
}, {
"code": "J01GB12",
"display": "Arbekacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB12",
"display": "J01GB12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Arbekacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Arbekacin",
"language": "no"
} ]
}, {
"code": "J01GB11",
"display": "Isepamicin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB11",
"display": "J01GB11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Isepamicin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Isepamicin",
"language": "no"
} ]
}, {
"code": "J01FG",
"display": "Streptogramins",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01F",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides, lincosamides and streptogramins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FG",
"display": "J01FG"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FG"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Streptogramins",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Streptograminer",
"language": "no"
} ]
}, {
"code": "J07AL",
"display": "Pneumococcal vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AL",
"display": "J07AL"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AL"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pneumococcal vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pneumokokkvaksiner",
"language": "no"
} ]
}, {
"code": "J07AG52",
"display": "Haemophilus influenzae B, combinations with pertussis and toxoids",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Haemophilus influenzae B vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AG52",
"display": "J07AG52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AG52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B, combinations with pertussis and toxoids",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B, kombinasjoner med pertussis og toksoider",
"language": "no"
} ]
}, {
"code": "J01CA08",
"display": "Pivmecillinam",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA08",
"display": "J01CA08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pivmecillinam",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pivmecillinam",
"language": "no"
} ]
}, {
"code": "J01XB02",
"display": "Polymyxin B",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Polymyxins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XB02",
"display": "J01XB02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XB02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Polymyxin B",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Polymyksin B",
"language": "no"
} ]
}, {
"code": "J01GB08",
"display": "Sisomicin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB08",
"display": "J01GB08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sisomicin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sisomicin",
"language": "no"
} ]
}, {
"code": "J01EA",
"display": "Trimethoprim and derivatives",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01E",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Sulfonamides and trimethoprim"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EA",
"display": "J01EA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Trimethoprim and derivatives",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Trimetoprim og derivater",
"language": "no"
} ]
}, {
"code": "J05AG07",
"display": "Elsulfavirine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Non-nucleoside reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AG07",
"display": "J05AG07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AG07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Elsulfavirine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Elsulfavirin",
"language": "no"
} ]
}, {
"code": "J01CG",
"display": "Beta-lactamase inhibitors",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01C",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactam antibacterials, penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CG",
"display": "J01CG"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-12-01T00:00:00Z",
"display": "2020-12-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CG"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Beta-lactamase inhibitors",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Beta-laktamasehemmere",
"language": "no"
} ]
}, {
"code": "J06BB12",
"display": "Encephalitis, tick borne immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB12",
"display": "J06BB12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Encephalitis, tick borne immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot encefalitt, skogflåttbåren",
"language": "no"
} ]
}, {
"code": "J07BX06",
"display": "Enterovirus 71 vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BX06",
"display": "J07BX06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2023-11-15T00:00:00Z",
"display": "2023-11-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BX06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Enterovirus 71 vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Enterovirus 71-vaksiner",
"language": "no"
} ]
}, {
"code": "J01XE",
"display": "Nitrofuran derivatives",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01X",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XE",
"display": "J01XE"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XE"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nitrofuran derivatives",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nitrofuranderivater",
"language": "no"
} ]
}, {
"code": "J01AA07",
"display": "Tetracycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA07",
"display": "J01AA07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetracycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetrasyklin",
"language": "no"
} ]
}, {
"code": "J01DD14",
"display": "Ceftibuten",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD14",
"display": "J01DD14"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD14"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftibuten",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftibuten",
"language": "no"
} ]
}, {
"code": "J04AM07",
"display": "Rifampicin, ethambutol and isoniazid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM07",
"display": "J04AM07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifampicin, ethambutol and isoniazid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifampicin, etambutol og isoniazid",
"language": "no"
} ]
}, {
"code": "J05AB15",
"display": "Brivudine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB15",
"display": "J05AB15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Brivudine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Brivudin",
"language": "no"
} ]
}, {
"code": "J06BB16",
"display": "Palivizumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB16",
"display": "J06BB16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2022-01-31T00:00:00Z",
"display": "2022-01-31T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Palivizumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Palivizumab",
"language": "no"
} ]
}, {
"code": "J05AX11",
"display": "Elvitegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX11",
"display": "J05AX11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-01-28T00:00:00Z",
"display": "2013-01-28T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2021-03-02T00:00:00Z",
"display": "2021-03-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Elvitegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Elvitegravir",
"language": "no"
} ]
}, {
"code": "J06BD01",
"display": "Palivizumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiviral monoclonal antibodies"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J06BB16",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Palivizumab"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD01",
"display": "J06BD01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-18T00:00:00Z",
"display": "2022-01-18T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Palivizumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Palivizumab",
"language": "no"
} ]
}, {
"code": "J07BH",
"display": "Rota virus diarrhea vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BH",
"display": "J07BH"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BH"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rota virus diarrhea vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rotavirusvaksiner",
"language": "no"
} ]
}, {
"code": "J04A",
"display": "Drugs for treatment of tuberculosis",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antimycobacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04A",
"display": "J04A"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04A"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Drugs for treatment of tuberculosis",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Midler til behandling av tuberkulose",
"language": "no"
} ]
}, {
"code": "J01ED05",
"display": "Sulfamethoxypyridazine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01ED",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Long-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01ED05",
"display": "J01ED05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01ED05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfamethoxypyridazine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfametoksypyridazin",
"language": "no"
} ]
}, {
"code": "J01DC01",
"display": "Cefoxitin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC01",
"display": "J01DC01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-06-07T00:00:00Z",
"display": "2010-06-07T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefoxitin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefoksitin",
"language": "no"
} ]
}, {
"code": "J01DC09",
"display": "Cefmetazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC09",
"display": "J01DC09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefmetazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefmetazol",
"language": "no"
} ]
}, {
"code": "J07BM03",
"display": "Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Papillomavirus vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BM03",
"display": "J07BM03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BM03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Papillomavirus (human typer 6, 11, 16, 18, 31, 33, 45, 52, 58)",
"language": "no"
} ]
}, {
"code": "J04AK",
"display": "Other drugs for treatment of tuberculosis",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AK",
"display": "J04AK"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AK"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other drugs for treatment of tuberculosis",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre midler til behandling av tuberkulose",
"language": "no"
} ]
}, {
"code": "J07BX05",
"display": "Respiratory syncytial virus vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BX05",
"display": "J07BX05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2023-08-01T00:00:00Z",
"display": "2023-08-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BX05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Respiratory syncytial virus vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Respiratoriske syncytialvirusvaksiner",
"language": "no"
} ]
}, {
"code": "J01CE05",
"display": "Pheneticillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE05",
"display": "J01CE05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-19T00:00:00Z",
"display": "2014-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pheneticillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Feneticillin",
"language": "no"
} ]
}, {
"code": "J01DD52",
"display": "Ceftazidime and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD52",
"display": "J01DD52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftazidime and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftazidim og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J05AP58",
"display": "Daclatasvir, asunaprevir and beclabuvir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP58",
"display": "J05AP58"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP58"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Daclatasvir, asunaprevir and beclabuvir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Daklatasvir, asunaprevir og beklabuvir",
"language": "no"
} ]
}, {
"code": "J05AP56",
"display": "Sofosbuvir, velpatasvir and voxilaprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP56",
"display": "J05AP56"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-08-18T00:00:00Z",
"display": "2017-08-18T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP56"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir, velpatasvir and voxilaprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sofosbuvir, velpatasvir og voksilaprevir",
"language": "no"
} ]
}, {
"code": "J05AF05",
"display": "Lamivudine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF05",
"display": "J05AF05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lamivudine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lamivudin",
"language": "no"
} ]
}, {
"code": "J06BB05",
"display": "Rabies immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB05",
"display": "J06BB05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rabies immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot hundegalskap",
"language": "no"
} ]
}, {
"code": "J06BB18",
"display": "Raxibacumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB18",
"display": "J06BB18"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2022-01-31T00:00:00Z",
"display": "2022-01-31T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB18"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Raxibacumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Raksibakumab",
"language": "no"
} ]
}, {
"code": "J07BX07",
"display": "Chikungunya vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BX07",
"display": "J07BX07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-12-16T00:00:00Z",
"display": "2024-12-16T00:00:00Z"
}
}, {
"code": "toDate",
"valueCoding": {
"code": "2025-06-03T00:00:00Z",
"display": "2025-06-03T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BX07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Chikungunya vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Chikungunyavaksiner",
"language": "no"
} ]
}, {
"code": "J05AP11",
"display": "Grazoprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP11",
"display": "J05AP11"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP11"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Grazoprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Grazoprevir",
"language": "no"
} ]
}, {
"code": "J01CF06",
"display": "Nafcillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase resistant penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CF06",
"display": "J01CF06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CF06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nafcillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nafcillin",
"language": "no"
} ]
}, {
"code": "J05AR03",
"display": "Tenofovir disoproxil and emtricitabine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR03",
"display": "J05AR03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tenofovir disoproxil and emtricitabine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tenofovirdisoproksil og emtricitabin",
"language": "no"
} ]
}, {
"code": "J01GB06",
"display": "Amikacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01GB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other aminoglycosides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01GB06",
"display": "J01GB06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01GB06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Amikacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Amikacin",
"language": "no"
} ]
}, {
"code": "J07AF01",
"display": "Diphtheria toxoid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Diphtheria vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AF01",
"display": "J07AF01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AF01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria toxoid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteritoksoid",
"language": "no"
} ]
}, {
"code": "J01CA05",
"display": "Carindacillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA05",
"display": "J01CA05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-08T00:00:00Z",
"display": "2014-10-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Carindacillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Karindacillin",
"language": "no"
} ]
}, {
"code": "J02AX04",
"display": "Caspofungin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J02AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antimycotics for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J02AX04",
"display": "J02AX04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2004-03-11T00:00:00Z",
"display": "2004-03-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J02AX04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Caspofungin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kaspofungin",
"language": "no"
} ]
}, {
"code": "J07AJ52",
"display": "Pertussis, purified antigen, combinations with toxoids",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Pertussis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AJ52",
"display": "J07AJ52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AJ52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pertussis, purified antigen, combinations with toxoids",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kikhoste, renset antigen, kombinasjoner med toksoider",
"language": "no"
} ]
}, {
"code": "J01DD03",
"display": "Cefsulodin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD03",
"display": "J01DD03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefsulodin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefsulodin",
"language": "no"
} ]
}, {
"code": "J07AE01",
"display": "Cholera, inactivated, whole cell",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Cholera vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AE01",
"display": "J07AE01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AE01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cholera, inactivated, whole cell",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kolera, inaktivert, helcelle",
"language": "no"
} ]
}, {
"code": "J05AB06",
"display": "Ganciclovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB06",
"display": "J05AB06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ganciclovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ganciklovir",
"language": "no"
} ]
}, {
"code": "J01XD",
"display": "Imidazole derivatives",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01X",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XD",
"display": "J01XD"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XD"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Imidazole derivatives",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Imidazolderivater",
"language": "no"
} ]
}, {
"code": "J07BN04",
"display": "Covid-19, protein subunit",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BN",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J07BX03",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Covid-19 vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BN04",
"display": "J07BN04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BN04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Covid-19, protein subunit",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Covid-19, proteinsubenhet",
"language": "no"
} ]
}, {
"code": "J04AB04",
"display": "Rifabutin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibiotics"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AB04",
"display": "J04AB04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AB04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifabutin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifabutin",
"language": "no"
} ]
}, {
"code": "J01DD63",
"display": "Ceftriaxone and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD63",
"display": "J01DD63"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-02-04T00:00:00Z",
"display": "2020-02-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD63"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftriaxone and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftriakson og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J01CG02",
"display": "Tazobactam",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CG02",
"display": "J01CG02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CG02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tazobactam",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tazobaktam",
"language": "no"
} ]
}, {
"code": "J06BD02",
"display": "Motavizumab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiviral monoclonal antibodies"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J06BB17",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Motavizumab"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD02",
"display": "J06BD02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-12-02T00:00:00Z",
"display": "2021-12-02T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Motavizumab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Motavizumab",
"language": "no"
} ]
}, {
"code": "J01DC10",
"display": "Cefprozil",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC10",
"display": "J01DC10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefprozil",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefprozil",
"language": "no"
} ]
}, {
"code": "J05AX27",
"display": "Favipiravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX27",
"display": "J05AX27"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX27"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Favipiravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Favipiravir",
"language": "no"
} ]
}, {
"code": "J01MA07",
"display": "Lomefloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA07",
"display": "J01MA07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lomefloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lomefloksacin",
"language": "no"
} ]
}, {
"code": "J05AR21",
"display": "Dolutegravir and rilpivirine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR21",
"display": "J05AR21"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2017-12-01T00:00:00Z",
"display": "2017-12-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR21"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Dolutegravir and rilpivirine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Dolutegravir og rilpivirin",
"language": "no"
} ]
}, {
"code": "J06BA02",
"display": "Immunoglobulins, normal human, for intravascular adm.",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immunoglobulins, normal human"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BA02",
"display": "J06BA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Immunoglobulins, normal human, for intravascular adm.",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin, normal human, til intravaskulær adm.",
"language": "no"
} ]
}, {
"code": "J01DI54",
"display": "Ceftolozane and beta-lactamase inhibitor",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DI",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other cephalosporins and penems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DI54",
"display": "J01DI54"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DI54"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ceftolozane and beta-lactamase inhibitor",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ceftolozan og beta-laktamasehemmer",
"language": "no"
} ]
}, {
"code": "J07CA01",
"display": "Diphtheria-poliomyelitis-tetanus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA01",
"display": "J07CA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-poliomyelitis-tetanus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-poliomyelitt-tetanus",
"language": "no"
} ]
}, {
"code": "J01EC03",
"display": "Sulfamoxole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01EC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Intermediate-acting sulfonamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01EC03",
"display": "J01EC03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-12-15T00:00:00Z",
"display": "2011-12-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01EC03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sulfamoxole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sulfamoksol",
"language": "no"
} ]
}, {
"code": "J01MA16",
"display": "Gatifloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01MA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fluoroquinolones"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01MA16",
"display": "J01MA16"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01MA16"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Gatifloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Gatifloksacin",
"language": "no"
} ]
}, {
"code": "J05AF01",
"display": "Zidovudine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF01",
"display": "J05AF01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Zidovudine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Zidovudin",
"language": "no"
} ]
}, {
"code": "J01DD01",
"display": "Cefotaxime",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Third-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DD01",
"display": "J01DD01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DD01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefotaxime",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefotaksim",
"language": "no"
} ]
}, {
"code": "J01RA13",
"display": "Norfloxacin and tinidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA13",
"display": "J01RA13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-12-17T00:00:00Z",
"display": "2014-12-17T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Norfloxacin and tinidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Norfloksacin og tinidazol",
"language": "no"
} ]
}, {
"code": "J05AB13",
"display": "Penciclovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB13",
"display": "J05AB13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Penciclovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Penciklovir",
"language": "no"
} ]
}, {
"code": "J06BB03",
"display": "Varicella/zoster immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB03",
"display": "J06BB03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Varicella/zoster immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot vannkopper/helvetesild",
"language": "no"
} ]
}, {
"code": "J01FA08",
"display": "Troleandomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA08",
"display": "J01FA08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Troleandomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Troleandomycin",
"language": "no"
} ]
}, {
"code": "J07BD52",
"display": "Measles, combinations with mumps and rubella, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Measles vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BD52",
"display": "J07BD52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BD52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Measles, combinations with mumps and rubella, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meslinger, kombinasjoner med kusma og rubella, levende svekket",
"language": "no"
} ]
}, {
"code": "J07AE02",
"display": "Cholera, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Cholera vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AE02",
"display": "J07AE02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AE02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cholera, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kolera, levende, svekket",
"language": "no"
} ]
}, {
"code": "J01RA15",
"display": "Cefixime and ornidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01RA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA15",
"display": "J01RA15"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2021-10-15T00:00:00Z",
"display": "2021-10-15T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA15"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefixime and ornidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefiksim og ornidazol",
"language": "no"
} ]
}, {
"code": "J07AH08",
"display": "Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH08",
"display": "J07AH08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokk A,C,Y,W-135, tetravalent renset polysakkarid antigen konjugert",
"language": "no"
} ]
}, {
"code": "J04AB05",
"display": "Rifapentine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibiotics"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AB05",
"display": "J04AB05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AB05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Rifapentine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Rifapentin",
"language": "no"
} ]
}, {
"code": "J01CA13",
"display": "Ticarcillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA13",
"display": "J01CA13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ticarcillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tikarcillin",
"language": "no"
} ]
}, {
"code": "J01XD03",
"display": "Ornidazole",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Imidazole derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XD03",
"display": "J01XD03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XD03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ornidazole",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ornidazol",
"language": "no"
} ]
}, {
"code": "J05AX21",
"display": "Pentanedioic acid imidazolyl ethanamide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX21",
"display": "J05AX21"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-07-11T00:00:00Z",
"display": "2018-07-11T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX21"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pentanedioic acid imidazolyl ethanamide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pentandioinsyreimidazolyletanamid",
"language": "no"
} ]
}, {
"code": "J01XX",
"display": "Other antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01X",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX",
"display": "J01XX"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-12T00:00:00Z",
"display": "2014-11-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre antibakterielle midler",
"language": "no"
} ]
}, {
"code": "J05AX09",
"display": "Maraviroc",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX09",
"display": "J05AX09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Maraviroc",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Maravirok",
"language": "no"
} ]
}, {
"code": "J01XE01",
"display": "Nitrofurantoin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nitrofuran derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XE01",
"display": "J01XE01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XE01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nitrofurantoin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nitrofurantoin",
"language": "no"
} ]
}, {
"code": "J01FA02",
"display": "Spiramycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA02",
"display": "J01FA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Spiramycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Spiramycin",
"language": "no"
} ]
}, {
"code": "J01DH06",
"display": "Tebipenem pivoxil",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Carbapenems"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DH06",
"display": "J01DH06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-12-20T00:00:00Z",
"display": "2018-12-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DH06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tebipenem pivoxil",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tebipenempivoksil",
"language": "no"
} ]
}, {
"code": "J01RA",
"display": "Combinations of antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01R",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01RA",
"display": "J01RA"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01RA"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Combinations of antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Kombinasjoner av antibakterielle midler",
"language": "no"
} ]
}, {
"code": "J01CA04",
"display": "Amoxicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA04",
"display": "J01CA04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Amoxicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Amoksicillin",
"language": "no"
} ]
}, {
"code": "J06BD04",
"display": "Ansuvimab",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiviral monoclonal antibodies"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD04",
"display": "J06BD04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-31T00:00:00Z",
"display": "2022-01-31T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ansuvimab",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ansuvimab",
"language": "no"
} ]
}, {
"code": "J04AK01",
"display": "Pyrazinamide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AK01",
"display": "J04AK01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AK01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pyrazinamide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pyrazinamid",
"language": "no"
} ]
}, {
"code": "J01DF",
"display": "Monobactams",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01D",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other beta-lactam antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DF",
"display": "J01DF"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-10T00:00:00Z",
"display": "2014-11-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DF"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Monobactams",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Monobaktamer",
"language": "no"
} ]
}, {
"code": "J07AG53",
"display": "Haemophilus influenzae B, combinations with meningococcus C, conjugated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Haemophilus influenzae B vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AG53",
"display": "J07AG53"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AG53"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B, combinations with meningococcus C, conjugated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B, kombinasjoner med meningokokk C, konjugert",
"language": "no"
} ]
}, {
"code": "J01",
"display": "Antibacterials for systemic use",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiinfectives for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01",
"display": "J01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-07-04T00:00:00Z",
"display": "2014-07-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Antibacterials for systemic use",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Antibakterielle midler til systemisk bruk",
"language": "no"
} ]
}, {
"code": "J07BM",
"display": "Papillomavirus vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BM",
"display": "J07BM"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BM"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Papillomavirus vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Papillomavirus vaksiner",
"language": "no"
} ]
}, {
"code": "J01AA12",
"display": "Tigecycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA12",
"display": "J01AA12"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2022-01-10T00:00:00Z",
"display": "2022-01-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA12"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tigecycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tigesyklin",
"language": "no"
} ]
}, {
"code": "J01DB05",
"display": "Cefadroxil",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "First-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DB05",
"display": "J01DB05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-06-07T00:00:00Z",
"display": "2010-06-07T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DB05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefadroxil",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefadroksil",
"language": "no"
} ]
}, {
"code": "J07AH09",
"display": "Meningococcus B, multicomponent vaccine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH09",
"display": "J07AH09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcus B, multicomponent vaccine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokk B, mulitkomponent vaksine",
"language": "no"
} ]
}, {
"code": "J04AK05",
"display": "Bedaquiline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AK",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AK05",
"display": "J04AK05"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AK05"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Bedaquiline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Bedakvilin",
"language": "no"
} ]
}, {
"code": "J01FF01",
"display": "Clindamycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Lincosamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FF01",
"display": "J01FF01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FF01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Clindamycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Klindamycin",
"language": "no"
} ]
}, {
"code": "J05AC",
"display": "Cyclic amines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AC",
"display": "J05AC"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AC"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cyclic amines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cykliske aminer",
"language": "no"
} ]
}, {
"code": "J05AR27",
"display": "Lamivudine, tenofovir disoproxil and dolutegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR27",
"display": "J05AR27"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-12-16T00:00:00Z",
"display": "2019-12-16T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR27"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lamivudine, tenofovir disoproxil and dolutegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Lamivudin, tenofovirdisoproksil og dolutegravir",
"language": "no"
} ]
}, {
"code": "J05AP02",
"display": "Telaprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AE11",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Telaprevir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP02",
"display": "J05AP02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Telaprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Telaprevir",
"language": "no"
} ]
}, {
"code": "J07BK",
"display": "Varicella zoster vaccines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07B",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Viral vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BK",
"display": "J07BK"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BK"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Varicella zoster vaccines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Varicella zoster vaksiner",
"language": "no"
} ]
}, {
"code": "J01FF02",
"display": "Lincomycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Lincosamides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FF02",
"display": "J01FF02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-28T00:00:00Z",
"display": "2014-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FF02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Lincomycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Linkomycin",
"language": "no"
} ]
}, {
"code": "J05AJ01",
"display": "Raltegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AJ",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Integrase inhibitores"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AX08",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Raltegravir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AJ01",
"display": "J05AJ01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2020-12-14T00:00:00Z",
"display": "2020-12-14T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AJ01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Raltegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Raltegravir",
"language": "no"
} ]
}, {
"code": "J07AH04",
"display": "Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH04",
"display": "J07AH04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokk A,C,Y,W-135, tetravalent renset polysakkarid antigen",
"language": "no"
} ]
}, {
"code": "J01CA01",
"display": "Ampicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Penicillins with extended spectrum"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CA01",
"display": "J01CA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Ampicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Ampicillin",
"language": "no"
} ]
}, {
"code": "J01A",
"display": "Tetracyclines",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01A",
"display": "J01A"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01A"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetracyclines",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetrasykliner",
"language": "no"
} ]
}, {
"code": "J05AF",
"display": "Nucleoside and nucleotide reverse transcriptase inhibitors",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05A",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Direct acting antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AF",
"display": "J05AF"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AF"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Nucleoside and nucleotide reverse transcriptase inhibitors",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Nukleosid og nukleotid reverstranskriptase-hemmere",
"language": "no"
} ]
}, {
"code": "J05AR04",
"display": "Zidovudine, lamivudine and abacavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR04",
"display": "J05AR04"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR04"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Zidovudine, lamivudine and abacavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Zidovudin, lamivudin og abakavir",
"language": "no"
} ]
}, {
"code": "J01CE02",
"display": "Phenoxymethylpenicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE02",
"display": "J01CE02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-19T00:00:00Z",
"display": "2014-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Phenoxymethylpenicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Fenoksymetylpenicillin",
"language": "no"
} ]
}, {
"code": "J01DC07",
"display": "Cefotiam",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DC",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Second-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DC07",
"display": "J01DC07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DC07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefotiam",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefotiam",
"language": "no"
} ]
}, {
"code": "J04BA03",
"display": "Aldesulfone sodium",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Drugs for treatment of lepra"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04BA03",
"display": "J04BA03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04BA03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Aldesulfone sodium",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aldesulfonnatrium",
"language": "no"
} ]
}, {
"code": "J01BA52",
"display": "Thiamphenicol, combinations",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Amphenicols"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01BA52",
"display": "J01BA52"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-24T00:00:00Z",
"display": "2014-11-24T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01BA52"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Thiamphenicol, combinations",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tiamfenikol, kombinasjoner",
"language": "no"
} ]
}, {
"code": "J07BA01",
"display": "Encephalitis, tick borne, inactivated, whole virus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Encephalitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BA01",
"display": "J07BA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Encephalitis, tick borne, inactivated, whole virus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Encefalitt, skogflåttbåren, inaktivert helvirus",
"language": "no"
} ]
}, {
"code": "J01DE03",
"display": "Cefozopran",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fourth-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DE03",
"display": "J01DE03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-13T00:00:00Z",
"display": "2010-01-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DE03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefozopran",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefozopran",
"language": "no"
} ]
}, {
"code": "J01CE03",
"display": "Propicillin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01CE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Beta-lactamase sensitive penicillins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01CE03",
"display": "J01CE03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2011-10-28T00:00:00Z",
"display": "2011-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01CE03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Propicillin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Propicillin",
"language": "no"
} ]
}, {
"code": "J07AH07",
"display": "Meningococcus C, purified polysaccharides antigen conjugated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Meningococcal vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AH07",
"display": "J07AH07"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2006-05-31T00:00:00Z",
"display": "2006-05-31T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AH07"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Meningococcus C, purified polysaccharides antigen conjugated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Meningokokk C, renset polysakkarid antigen konjugert",
"language": "no"
} ]
}, {
"code": "J05AB09",
"display": "Famciclovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AB09",
"display": "J05AB09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AB09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Famciclovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Famciklovir",
"language": "no"
} ]
}, {
"code": "J06BB13",
"display": "Pertussis immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB13",
"display": "J06BB13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pertussis immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot kikhoste",
"language": "no"
} ]
}, {
"code": "J05AR29",
"display": "Emtricitabine, tenofovir alafenamide and dolutegravir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR29",
"display": "J05AR29"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR29"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine, tenofovir alafenamide and dolutegravir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin, tenofoviralafenamid og dolutegravir",
"language": "no"
} ]
}, {
"code": "J01DE01",
"display": "Cefepime",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01DE",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Fourth-generation cephalosporins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01DE01",
"display": "J01DE01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2010-01-27T00:00:00Z",
"display": "2010-01-27T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01DE01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Cefepime",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Cefepim",
"language": "no"
} ]
}, {
"code": "J07AG51",
"display": "Haemophilus influenzae B, combinations with toxoids",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AG",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Haemophilus influenzae B vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AG51",
"display": "J07AG51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AG51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B, combinations with toxoids",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Haemophilus influenzae B, kombinasjoner med toksoider",
"language": "no"
} ]
}, {
"code": "J05AP03",
"display": "Boceprevir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AP",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HCV infections"
}
}, {
"code": "previousVersion",
"valueCoding": {
"code": "J05AE12",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Boceprevir"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AP03",
"display": "J05AP03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2018-01-01T00:00:00Z",
"display": "2018-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AP03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Boceprevir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Boceprevir",
"language": "no"
} ]
}, {
"code": "J07AM51",
"display": "Tetanus toxoid, combinations with diphtheria toxoid",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetanus vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07AM51",
"display": "J07AM51"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07AM51"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetanus toxoid, combinations with diphtheria toxoid",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetanustoksoid, kombinasjoner med difteritoksoid",
"language": "no"
} ]
}, {
"code": "J01XX03",
"display": "Clofoctol",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01XX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XX03",
"display": "J01XX03"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-13T00:00:00Z",
"display": "2014-10-13T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XX03"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Clofoctol",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Klofoktol",
"language": "no"
} ]
}, {
"code": "J05AR26",
"display": "Darunavir and ritonavir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR26",
"display": "J05AR26"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2019-12-16T00:00:00Z",
"display": "2019-12-16T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR26"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Darunavir and ritonavir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Darunavir og ritonavir",
"language": "no"
} ]
}, {
"code": "J05AR08",
"display": "Emtricitabine, tenofovir disoproxil and rilpivirine",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AR",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antivirals for treatment of HIV infections, combinations"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AR08",
"display": "J05AR08"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AR08"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Emtricitabine, tenofovir disoproxil and rilpivirine",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Emtricitabin, tenofovirdisoproksil og rilpivirin",
"language": "no"
} ]
}, {
"code": "J05AX13",
"display": "Umifenovir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AX",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antivirals"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AX13",
"display": "J05AX13"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AX13"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Umifenovir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Umifenovir",
"language": "no"
} ]
}, {
"code": "J07BF02",
"display": "Poliomyelitis oral, trivalent, live attenuated",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07BF",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Poliomyelitis vaccines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07BF02",
"display": "J07BF02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07BF02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Poliomyelitis oral, trivalent, live attenuated",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Poliomyelitt oral, trivalent, levende, svekket",
"language": "no"
} ]
}, {
"code": "J04AM09",
"display": "Pyrazinamide, ethambutol, isoniazid and lomefloxacin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AM",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Combinations of drugs for treatment of tuberculosis"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AM09",
"display": "J04AM09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AM09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Pyrazinamide, ethambutol, isoniazid and lomefloxacin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Pyrazinamid, etambutol, isoniazid og lomefloksacin",
"language": "no"
} ]
}, {
"code": "J04AD02",
"display": "Tiocarlide",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J04AD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Thiocarbamide derivatives"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J04AD02",
"display": "J04AD02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J04AD02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tiocarlide",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tiokarlid",
"language": "no"
} ]
}, {
"code": "J05AH02",
"display": "Oseltamivir",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J05AH",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Neuraminidase inhibitors"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J05AH02",
"display": "J05AH02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J05AH02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Oseltamivir",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Oseltamivir",
"language": "no"
} ]
}, {
"code": "J07CA06",
"display": "Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J07CA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Bacterial and viral vaccines, combined"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J07CA06",
"display": "J07CA06"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J07CA06"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Difteri-haemophilus influenzae B-kikhoste-poliomyelitt-tetanus",
"language": "no"
} ]
}, {
"code": "J01G",
"display": "Aminoglycoside antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01G",
"display": "J01G"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-01-03T00:00:00Z",
"display": "2014-01-03T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01G"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Aminoglycoside antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Aminoglykosider",
"language": "no"
} ]
}, {
"code": "J06AA02",
"display": "Tetanus antitoxin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Immune sera"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06AA02",
"display": "J06AA02"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06AA02"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Tetanus antitoxin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Tetanusantitoksin",
"language": "no"
} ]
}, {
"code": "J01FA01",
"display": "Erythromycin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01FA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Macrolides"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01FA01",
"display": "J01FA01"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-10-20T00:00:00Z",
"display": "2014-10-20T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01FA01"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Erythromycin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Erytromycin",
"language": "no"
} ]
}, {
"code": "J01D",
"display": "Other beta-lactam antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antibacterials for systemic use"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01D",
"display": "J01D"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-12T00:00:00Z",
"display": "2014-11-12T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01D"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Other beta-lactam antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Andre beta-laktam antibakterielle midler",
"language": "no"
} ]
}, {
"code": "J01AA10",
"display": "Penimepicycline",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01AA",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Tetracyclines"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01AA10",
"display": "J01AA10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2013-10-28T00:00:00Z",
"display": "2013-10-28T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01AA10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Penimepicycline",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Penimepisyklin",
"language": "no"
} ]
}, {
"code": "J06BD09",
"display": "Sipavibart",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BD",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Antiviral monoclonal antibodies"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BD09",
"display": "J06BD09"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2024-04-26T00:00:00Z",
"display": "2024-04-26T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BD09"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Sipavibart",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Sipavibart",
"language": "no"
} ]
}, {
"code": "J01XC",
"display": "Steroid antibacterials",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J01X",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Other antibacterials"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J01XC",
"display": "J01XC"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2014-11-21T00:00:00Z",
"display": "2014-11-21T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J01XC"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Steroid antibacterials",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Steroid antibakterielle midler",
"language": "no"
} ]
}, {
"code": "J06BB10",
"display": "Diphtheria immunoglobulin",
"property": [ {
"code": "parentATC",
"valueCoding": {
"code": "J06BB",
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e9f15a26-d384-48c2-a74d-3fa95f44a9dc",
"display": "Specific immunoglobulins"
}
}, {
"code": "ATCCode",
"valueCoding": {
"code": "J06BB10",
"display": "J06BB10"
}
}, {
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
}, {
"code": "internalCode",
"valueCoding": {
"code": "J06BB10"
}
}, {
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
} ],
"designation": [ {
"use": {
"code": "term-name"
},
"value": "Diphtheria immunoglobulin",
"language": "en"
}, {
"use": {
"code": "term-name"
},
"value": "Immunglobulin mot difteri",
"language": "no"
} ]
} ],
"version": null
}